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SPAG16 is the murine orthologue of Chlamydomonas reinhardtii PF20, a protein known 
to be essential to the structure and function of the “9 + 2” axoneme. The “9 + 2” axoneme 
provides the cytoskeletal core of all eukaryotic motile cilia and flagella. In 
Chlamydomonas, the Pf20 gene encodes a single protein present in the central pair of 
the axoneme. Loss of Pf20 prevents central pair assembly and results in flagellar 
paralysis. The murine Spag16 gene encodes two proteins. While 71 kDa SPAG16L is 
found in all murine cells with motile cilia or flagella, 35 kDa SPAG16S transcript and 
protein are detected only in male germ cells, suggesting a unique role distinct from 
general axoneme formation. Transgenic mouse studies published previously by our lab 
have shown that abrogation of both SPAG16 isoforms causes arrest of spermatogenesis, 
and the mutant allele is not transmitted to offspring by chimeric males. Mice homozygous 
for a knock-out of SPAG16L alone are infertile, but show no abnormalities in 
  
spermatogenesis. The defects seen in chimeric Spag16 mutant mice, unaccounted for by 
loss of SPAG16L, indicate a possible role for SPAG16S in the specialized process of 
male germ cell development. Our results demonstrate that SPAG16S is predominantly 
found in specific regions within the nucleus of round spermatids. These nuclear sub-
domains also contain SC35, a known marker of nuclear speckles enriched in pre-mRNA 
splicing factors. Putative interaction partners of SPAG16S are also shown to play critical 
roles in the peri-nuclear region during the round spermatid transition to the condensation 
and elongation stage of spermiogenesis, the final specialization point in sperm 
development. The distinct localization of SPAG16S at this critical juncture, its interaction 
with discretely localized proteins at a critical temporal junction in spermatogenesis, and 
its ability to modulate SPAG16L expression, suggest that SPAG16S plays an important 
role in the gene expression machinery of male germ cells, and represents an 
evolutionary distinction in axoneme gene function.
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Chapter 1:  General Introduction 
 
Early Discoveries 
In the mid-17th century, a one-time haberdasher and civic official in Delft began to perfect 
a proprietary approach to glass lens manufacture, enabling him to produce smaller, more 
perfect spheres than any previously available. At a time when most microscopic 
observations were still severely limited in magnification, Leeuwenhoek produced single 
lens, simple microscopes capable of up to 300X amplification (Huxley 2007). 
Leeuwenhoek’s carefully honed spheres became one of the most important technological 
breakthroughs of modern science, granting powerful new opportunities to explore the 
sub-microscopic world. Over five decades of active investigation, Leeuwenhoek became 
the first scientist to describe muscle fibers, blood flow, and structures of bacteria, earning 
the title “Father of Microbiology” for his groundbreaking reports (Dobell and 
Leeuwenhoek 1932). 
 
While he is most famous for his descriptions of bacterial structure, Leeuwenhoek 
produced a diverse body of work. After years of wrestling with one of the most shocking 
discoveries afforded by his inquiries, in 1677 he penned a letter to the Royal Society of 
London, excitedly describing a new finding: 
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“… and I have seen so great a number of living animalcules… in it, that sometimes more 
than a thousand were moving about in an amount of material the size of a grain of 
sand…” (letter to W. Brouncker, President of the Royal Society of London, Nov 1677, in 
(Leeuwenhoek and Rijnberk 1939)) 
 
Leeuwenhoek was describing, for the first time in history, the microscopic contents of 
human semen. His observations challenged Church doctrine that organisms were 
fundamentally divided into two groups: large, procreating, creatures, and small, 
spontaneously generating life forms (letter to Anthonio Magliabechi, Oct 1699, in 
(Leeuwenhoek and Rijnberk 1939)). Though Leeuwenhoek himself was a devout 
Calvinist, and indeed was profoundly troubled by the implications of his findings (Huxley 
2007), his report posed a fundamental challenge to contemporary European beliefs on 
the nature of the human soul - procreation could no longer be assumed to result from a 
purely spiritual union. Leeuwenhoek’s work suggested that human life might begin from 
just one of millions of tiny, single cells, each with the potential to give rise to a new being. 
 
Strategies in Contraception 
In bi-gendered species, males are defined as the gender producing numerous small, 
motile gametes, termed spermatozoa (Bishop and Walton “Spermatogenesis and the 
structure of mammalian spermatozoa” in (Marshall, Lamming et al. 1984))(Birkhead, 
Pellatt et al. 1988). Evolutionary biologists have interpreted this strategy as a 
consequence of the challenge of genetic competition; for the non-gestating partner, 
producing more gametes increases the likelihood of reproductive success (Kilgallon and 
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Simmons 2005; Parker and Ball 2005). It has even been proposed that quality and 
quantity of male gamete output varies dynamically with perceived reproductive 
competition, a complex psychophysiological response to the challenge of ensuring 
genetic continuity (Friedmann 1981; Law 1986). 
 
As a result of this prodigious and continuous production of viable sperm, male 
contraception requires fundamentally different approaches than those collectively 
referred to as “the Pill,” the array of hormone regimens that suppress female ovulation. 
The human female menstrual cycle is a well characterized and highly regulated series of 
physiological changes focused on the production, typically, of a single ovum. Over the 
course of an average 28-29 days cycle (Clifton, Kaneda et al. 2008), the endocrine 
system primes the uterus to become a hospitable environment for implantation and 
gestation. If fertilization does not occur, the uterine lining is secreted and a new round of 
hormonal surges triggers the cycle to begin again. 
 
Female oral contraceptives, which employ progesterone alone or in combination with 
estrogen as well, are employed by 18% of contraceptive users worldwide (National 
Prescribing Service 2007). When taken perfectly as prescribed (usually a daily 
administration in the case of oral dosing), pregnancy rates are around 0.3% (Fu, Darroch 
et al. 1999; Hatcher 2007; Halpern, Lopez et al. 2011). However, typical real world 
adherence results in a failure rate of approximately 8% during the first year of use 
(Hassan and Killick 2004). 
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Contraceptive failure is not the only drawback to these medications – reported side 
effects include impaired recovery of fertility (Shufelt and Bairey Merz 2009; Blanco-
Molina and Monreal 2010), deep venous thrombosis (La Vecchia and Bosetti 2009; 
Cibula, Gompel et al. 2010), and certain types of neoplasm (Keith, Keith et al. 1975; 
Heinemann, Saad et al. 2005; Heinemann, Saad et al. 2005). While these medications 
are highly effective, and the vast majority of studies have demonstrated the health risks 
of hormonal contraceptives to be quite limited, both the reality of their side effects and 
patient concerns arising from perceived risk suggest that alternative approaches are 
highly desirable. 
 
Male Hormone Contraception 
Reports have indicated that the majority of men would be willing to take a perfected oral 
contraceptive pill (Oudshoorn 2003), and researchers have been optimistic about 
producing one for decades. Over 50 years have passed since leaders in China and India 
labeled male contraceptives as the critical missing element in population control 
programs (Zatuchni, Goldsmith et al. 1986). Early research sought a quick-acting agent 
to disrupt sperm production by direct inhibition of hormone function, and later by targeting 
various steps in the endocrine control pathway (reviewed in (Heckel, Rosso et al. 1951)), 
based on the early observation that testosterone itself was antispermatogenic in rats 
(Steinberger and Smith 1977; Swerdloff, Peterson et al. 1978). Many of the first studies 
focused on estrogens, which have long been used in treatment of prostate cancer and 
are known to disrupt spermatogenesis. However, the long-term feminizing effects of 
estrogen treatment are unacceptable, and require counter-administration of testosterone 
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(Oudshoorn 2003), which still does not fully overcome reduced libido, acne, testicular 
shrinkage, and breast growth (Farrell, Joshua et al. 1975). In addition to creating a 
complex clinical protocol for administration, androgens also carry their own risks, 
including hepatic damage (Muldoon, Mahesh et al. 1982) and neoplasm (Zatuchni, 
Goldsmith et al. 1986). Moreover, onset may take up to several years (NJ Alexander 
“Sites for Disruption of Male Fertility” in (Prasad and Diczfalusy 1983; Qian and Wang 
1984)).  
 
Gossypol 
Clearly, an approach is necessary that targets male fertility more specifically, rather than 
mimicking the strategy of female oral contraceptives. In the 1980s, significant research 
efforts focused on gossypol, a naturally-occurring chemical derived from cotton seeds 
(Shepu, Shudong et al. 1980; Wen 1980). A polpyhenol, gossypol’s direct cellular target 
remains controversial. Despite limited mechanistic data, gossypol was reported to be 
safe and effective following a trial in 4,000 Chinese men, who exhibited decrease in 
motile sperm and eventual oligozoospermia and azoospermia (Coutinho, Athayde et al. 
2000). Subsequent studies have in fact demonstrated that gossypol is well tolerated 
during continuous dosing, and potential toxicities such as hypokalemia can be 
significantly diminished by routine clinical check-up (Liu and Lyle 1987; Liu, Lyle et al. 
1987; Liu, Lyle et al. 1987). However, gossypol appears to be too potent; infertility is 
markedly prolonged in up to 50% of users, and, critically, is irreversible in 10-20% of 
users after administration is stopped (Ansbacher 1971; Shulman, Zappi et al. 1972). 
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Vasectomy 
Vasectomy, a surgical severing and tying off of the vas deferens, is highly effective in 
preventing male fertility, and has been safely practiced for decades. The procedure is 
widely available, is performed on an out-patient basis, and requires less than half an 
hour. For men who desire a permanent approach to contraception, vasectomy offers a 
safe and convenient way to achieve this goal without major lifestyle changes. 
 
However, numerous studies have raised concerns regarding unforeseen side effects of 
vasectomy. It is well established that circulating levels of anti-sperm antibodies are 
increased following vasectomy (Nagarkatti and Rao 1976; McDonald and Halliday 1992), 
and cell-mediated immune responses to spermatozoa have been observed as well 
(Witkin, Zelikovsky et al. 1982). Additionally, immune complexes in general are elevated 
in vasectomized men (Alexander and Clarkson 1978; Clarkson and Alexander 1980). 
Several reports have also proposed a link between vasectomy and cardiovascular 
disease (Ross, Paganini-Hill et al. 1983; Sidney 1987; Honda, Bernstein et al. 1988; 
Newell, Fueger et al. 1989). Early studies also suggested an increased risk of certain 
genitourinary concerns, including prostate (Goldacre, Clarke et al. 1978; Strader, Weiss 
et al. 1988; Thornhill, Conroy et al. 1988; Cale, Farouk et al. 1990) and testicular cancers 
(Schwingl and Guess 2000; Kohler, Fazili et al. 2009). 
 
Follow-up studies and meta-analyses have repeatedly shown these links between 
vasectomy and pathologies to be unsubstantiated, and have suggested the surgery is 
safe for the vast majority of potential patients (reviewed in (Lee, Li et al. 2008)). 
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Nevertheless, there are substantial costs to vasectomy. The procedure is irreversible in 
just under half of cases (Robles, Martinez et al. 1987; Santiso 1988; Sharma and Sharma 
1996), and acceptance varies significantly amongst different cultures (Inhorn 2009). Even 
in groups where vasectomy is regularly employed as a contraception technique, it is not 
uncommon for men to feel somewhat diminished by knowledge of their own sterility, 
stating e.g. “It’s a bit unmanly in a way” (Roberts 2000; Rowlands 2002; Pollack 2003). 
Both US and UK guidelines state that the surgery should be viewed as a permanent 
sterilization, and should be performed only on patients who definitely do not want to 
father children in the future (Fenster and McLoughlin 1981; Belker, Thomas et al. 1991; 
Potts, Pasqualotto et al. 1999; Sandlow, Westefeld et al. 2001). Despite careful pre-
operational screening, 3-6% of vasectomy patients eventually seek reversal (Fenster and 
McLoughlin 1981; Belker, Thomas et al. 1991), and the more time that passes after 
vasectomy, the lower the chances are that fertility will be successfully restored 
(Birenbaum-Carmeli, Carmeli et al. 1995). 
 
Male Infertility 
Unlike the nascent state of male birth control, medical technology is somewhat more 
advanced in the treatment of impaired male fertility. Nevertheless, the basic framework of 
knowledge regarding andrology and male infertility remains limited (Cates, Farley et al. 
1985; World Health Organization 1987; Outlook 2002; Potter and Hanin 2005). Estimates 
shown that approximately 1 in 7 couples will experience difficulty conceiving (Bhasin 
2007), and that in instances of sub-fertility, male factor infertility is involved in roughly 
50% of cases (Whorton, Krauss et al. 1977; Wyrobek, Gordon et al. 1983; Schrader, 
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Turner et al. 1991). Moreover, infertility rates have been widely reported to be increasing, 
with links drawn to environmental and occupational toxins (Auger, Kunstmann et al. 
1995; Irvine, Cawood et al. 1996; Selevan, Borkovec et al. 2000; Jorgensen, Carlsen et 
al. 2002). Most studies have focused on industrialized nations, citing reduced sperm 
counts and increased rates of abnormal sperm morphology in young men (Olsen, Bodner 
et al. 1995; Fisch, Goluboff et al. 1996), though these findings have been somewhat 
controversial (Irvine, Cawood et al. 1996). Reports not only point out trends of reduced 
male fertility, but tend towards alarmist tones, calling “urgently” for more data (Katz 1994; 
Birenbaum-Carmeli, Carmeli et al. 1995; Inhorn 2004). Social scientists have reported 
widely that male infertility seems more strongly stigmatized (Carmeli et al. in (Inhorn 
2009)) citing anecdotes of severe anxiety at the prospect of being completely infertile: 
 
“The men feel so bad if they don’t have sperm. They will be so happy to know that they 
have sperm, even if none of them are motile. When I tell them they have sperm, they are 
crying. Sometimes they hug me. They speak about [sperm] donation, and he feels 
miserable. I spoke to a man who was told he was azoospermic. I told him to bring me a 
slide of his testis. I put it on my electro-microscope and showed him where the sperm 
were. I told him, “You are not azoospermic.” He was holding me and kissing me. (from H 
Goldberg in (Inhorn and Balen 2002; Teman 2003)) 
 
In fact, current fertility treatments have made possible the successful use of lower quality 
and even immotile sperm. While research has focused more strongly on female infertility 
(reviewed in (Rodriguez-Martinez 2006)) advances in fertility drugs and in the techniques 
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of in vitro fertilization (IVF) have reduced the need for quantity and quality of sperm that 
would traditionally be required for unperturbed fertility (Maggiulli, Neri et al.; Setti, 
Figueira et al. 2010). Micromanipulation and advanced screening of male gametes has 
allowed a targeted, “modified” approach to intracytoplasmic sperm injection (IMSI, a 
modified approach to ICSI) that has raised successful pregnancy rates in couples with 
clinically-diagnosed male infertility on par with those of couples requiring simple in vitro 
semination (Fortunato and Tosti 2011). While these advances have been welcomed by 
hopeful couples and by practitioners, concerns have been raised that the practice of in 
vitro fertilization produces more birth defects and subsequent pathologies than are 
observed with traditional procreation, perhaps owing to reduced quality of gametes used 
and imperfect conditions of the in vitro environment (Lokman and Moore; Nagano 2011). 
Researchers have continued to focus on methods to induce the production of improved 
sperm, but these techniques remain elusive (Austin and Short 1972). 
 
Spermatogenesis 
The most promising approaches to both targeted male contraception and enhanced male 
fertility lie in a deeper understanding of spermatogenesis, the highly specialized process 
that generates male gametes capable of: 1) directed motility; 2) recognition of the female 
ovum; 3) binding to the ovum; 4) penetration of and fusion with the ovum, i.e. 
capacitation (Clermont and Trott 1969). This process takes a total of 35 days in mice, 
and 74 days in humans (Brehm and Steger 2005). Male gametes are produced from a 
population of spermatogonial stem cells, and derive from a maturation process that can 
be divided into three distinct stages (Hess and Renato de Franca 2008). 
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In the first stage of spermatogenesis, spermatogonial stem cells divide by mitosis, with 
one daughter cell continuing the stem cell population while the other differentiates and 
matures. In the second stage of spermatogenesis, meiotic division of a primary 
spermatocyte results in the production of four round spermatids. In the final differentiation 
step, spermiogenesis, round spermatids produced by meiosis mature into functional 
spermatozoa. In this final step, differentiating sperm develop specialized structures, such 
as the flagellum, acrosome, and condensed nucleus, critical to their unique reproductive 
function. 
 
Seminiferous Tubules 
The majority of the process of spermatogenesis takes place within the seminiferous 
tubules of the testis (Skinner and Griswold 2005). Seminiferous tubules are arranged as 
rings, with undifferentiated cells at the periphery maturing as they move towards the 
lumen. This architecture is established by the seminiferous epithelium, consisting of germ 
cells interspersed with Sertoli cells, the only somatic cells present within the tubules and 
a critical participant in sperm maturation (R Hess and LR Franca in (Hess and Renato de 
Franca 2008))(Leblond and Clermont 1952). 
 
While the seminiferous epithelium represents a mixture of Sertoli cells and various germ 
cell types, investigators have divided the epithelium into several stages based on the 
mixture of cells present in a given tubular cross section, defining twelve stages (I-XII) in 
rodents (Clermont 1963) and six stages (I-VI) in men (Russell 1990). This convention 
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provides a common framework and vocabulary for researchers to address pathologies 
that perturb the normal distribution within the cycle of cells undergoing spermatogenetic 
differentiation. Spermatogenesis has been studied most extensively in the mouse, where 
staging is commonly grouped into ‘Early’ stages I-V, ‘Middle’ stages VI-VIII, and ‘Late’ 
stages IX-XII (Grudzinskas and Yovich 1995). 
 
Epididymis 
As haploid round spermatids elongate and condense during spermiogenesis, the 
maturing spermatozoa are released into the seminiferous tubule lumen. Final sperm 
maturation takes place as spermatozoa move from the lumen into the epididymis, where 
they are stored until ejaculation (reviewed by HDM Moore in (Hess and Chen 1992)). 
Storage time varies among animals, and is known to be affected by scrotal temperature, 
which also modulates the duration of spermatogenesis (Bedford 1965; Bedford 1967; 
Cooper 1998; Toshimori 1998). As spermatozoa move into the epididymis, they are still 
not functionally mature – they lack forward motility and the ability to recognize the oocyte 
zona pellucida (Sullivan, Frenette et al. 2007). These functions are acquired within the 
epididymis under the direction of a group of molecules collectives designated 
“epididymosomes” (Toshimori, Kuwajima et al. 1999). Impairment of this process limits 
sperm motility and significantly reduces fertility (Connell 1976). 
 
Leydig cells 
Both Sertoli cells and spermatogonia are supported by paracrine signaling from Leydig 
cells residing in the interstitial space outside the seminiferous tubules. While other cells, 
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such as fibroblasts, macrophages, and mast cells, are also present in the interstitium 
(Schulze 1984), Leydig cells are the primary resident cell type with a direct and 
necessary effect on spermatogenesis. The primary responsibility of Leydig cells is to 
produce testosterone in response to luteinizing hormone (LH) (Andersson, Jorgensen et 
al. 2004). The testosterone released by Leydig cells diffuses to Sertoli cells and 
spermatogonia within the seminiferous tubule, effecting critical paracrine stimulation of 
spermatogenesis. As 12-15% of men with diminished spermatogenesis exhibit reduced 
testosterone levels, it can be inferred that proper Leydig cell function is highly important 
to male fertility (Dym 1994; Timpl 1996; Timpl and Brown 1996). 
 
Sertoli cells 
Interspersed between spermatogonial stem cells, Sertoli cells form physical contact with 
the seminiferous epithelium’s basement membrane of type IV collagen and laminins 
(Bawa 1963; Flickinger and Fawcett 1967). Sertoli cells play several important roles 
during spermatogenesis, including: nutrition and support of germ cells; maintenance of 
tight junctions for seminiferous tubule compartmentalization as a protected 
microenvironment (Russell and Griswold 1993; Hess and Renato de Franca 2008); 
release of spermatids into the lumen; secretion of growth factors; phagocytosis of 
degenerating germ cells and of residual body cytoplasm shed by mature sperm (Van 
Haaster, De Jong et al. 1992; Hess, Cooke et al. 1993; Sharpe, McKinnell et al. 2003). It 
has been established in numerous studies that the number of Sertoli cells shows a strong 
correlation with the maximal resulting sperm production (Kormano 1967; Setchell 2008). 
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The tight junctions of Sertoli cells are critical to the integrity of the “blood-testis barrier” 
that generates a specific and controlled environmental within seminiferous tubules of 
post-pubertal mammalian testes (Witkin, Jeremias et al. 1996). This barrier creates an 
immunologically-privileged compartment from which circulating antibodies and immune 
cells are excluded (Teuscher, Wild et al. 1982; Yule, Montoya et al. 1988; Tung and 
Teuscher 1995). Some reports have suggested that this barrier is incomplete, with the 
result that germ cells occasionally pass the barrier and become subject to immune-
mediated attack (Russell 1978). Critically, this barrier must occasionally open to allow 
developing spermatids into the seminiferous tubule lumen (Mruk and Cheng 2004), with 
competing theories (reviewed in (Russell 1990; Chiarini-Garcia, Hornick et al. 2001)) 
debating the mechanism of this controlled traffic flow. As a critical step in sperm 
maturation, this juncture represents a potential bottleneck target for contraception. 
 
Mitosis in Spermatogonia 
Spermatogonia are diploid (2n) cells comprising the earliest stages of spermatogenesis 
as well as the fully undifferentiated spermatogonial stem cell population. In rodents, 
electron microscopy evaluation of heterochromatin distribution in developing 
spermatogonia has resulted in sub-classification into four groups: undifferentiated (stem) 
cells; differentiated type A (further sub-divided into A1-A4); intermediate (In); and type B 
(B) (Brinster 2002; Ogawa, Ohmura et al. 2005; Oatley and Brinster 2006). Three such 
classifications are used in humans: undifferentiated, type A differentiated, and type B (de 
Rooij and Russell 2000; Aponte, van Bragt et al. 2005; Hofmann, Braydich-Stolle et al. 
2005; Hess, Cooke et al. 2006; Oatley and Brinster 2006; Brinster 2007). 
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The spermatogonial stem cell population is maintained by mitotic division, under which 
one daughter cell differentiates while the other maintains the stem cell line. During 
mitosis and maturation of differentiated spermatogonia, a relatively limited number of 
factors (e.g. c-kit, Vitamin A) and proteins have been identified as initiators of key 
signaling events (Clermont 1972). The number of regulated mitotic divisions varies 
characteristically by species (Russell, Chiarini-Garcia et al. 2002), and it is during this 
step in maturation that apoptotic loss of germ cells occurs, as a normal facet of 
spermatogenesis in all mammals thus far investigated (Franca, Avelar et al. 2005; Luiz 
Renato, Russell et al. 2006). For each differentiated type A spermatogonium, only 2-3 
spermatocytes result from mitotic divisions capable of producing 8-12 (Hess and Renato 
de Franca 2008), demonstrating that apoptotic culling of the developing spermatogonial 
population is a critical regulator of gamete production. It has been proposed (Sharpe, 
McKinnell et al. 2003) that programmed cell death may result from a density-dependent 
limit on spermatogonial cell expansion established by the number of available Sertoli 
cells, which would explain the observation that Sertoli cell population is a critical 
determinant of maximal sperm production (Toshimori 2009). 
 
Meiosis 
The end products of spermatogonial maturation, spermatocytes, represent the beginning 
of meiotic prophase I. Unlike female oocytes, which do not complete meiosis until 
ovulation, spermatocytes progress through all steps of meiosis prior to spermiation 
(Russell 1977; Weber, Russell et al. 1983). While in early stages they still rest on the 
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basement membrane, as they develop spermatocytes move through the blood-testis 
barrier of Sertoli cell junctions (as discussed earlier), entering the seminiferous tubule 
lumen for further development (Franca and Cardoso 1998; Franca, Avelar et al. 2005). 
During this process, spermatocytes also increase significantly in size as they begin 
preparing the appropriate cellular contents necessary at the haploid spermatid stage 
(Hess and Renato de Franca 2008). 
 
During meiosis I, 4n primary spermatocytes divide to produce secondary 2n 
spermatocytes, a relatively transient step in spermatozoan differentiation (Sassone-Corsi 
1997; Eddy 2002). Meiosis II sees the division of secondary spermatocytes into haploid 
(1n) round spermatids, which begin the profound biochemical and cytological 
restructuring of spermiogenesis. 
 
Spermiogenesis 
Following meiosis, haploid round spermatids initiate a programmed system of robust 
transcriptional activity, which has been extensively reviewed in the literature (Schmidt, 
Ohbayashi et al. 1997). Dramatic increases in expression of transcription factors and 
polymerases correspond with a need to rapidly produce necessary mRNAs and proteins 
before chromatin is condensed in the tightly packaged nucleus of elongating spermatids 
(Blendy, Kaestner et al. 1996; Nantel, Monaco et al. 1996).  
 
While several testis-specific genes and isoforms play important roles, perhaps none are 
so important as cAMP-responsive element modulator (CREM), a master transcription 
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factor that regulates promoter function of many haploid spermatid genes (Steger, 
Klonisch et al. 1999). In studies of infertile men with spermatogenesis arrest at the round 
spermatid stage, CREM mRNA (Weinbauer, Behr et al. 1998) and protein (Braun, 
Peschon et al. 1989) have both been reported to be severely reduced. 
 
Concurrent with spermiogenesis-specific transcription, translation of resulting mRNAs is 
regulated by the binding of cytoplasmic repressor proteins to the 3’-UTRs (Kwon and 
Hecht 1993). A 17-nucleotide motif within the 3’-UTR of protamine mRNAs has been 
pinpointed as a critical signaling element dubbed the “Z-box,” which coordinates 
expression of genes involved in nuclear re-packaging (Steger, Failing et al. 2001) and 
mediates temporary storage of transcripts in ribonucleoprotein (RNP) particles (Singh 
and Rao 1987; Kundu and Rao 1995; Caron, Veilleux et al. 2001). 
 
Nuclear Packaging 
As haploid spermatids elongate and condense within the seminiferous tubules, re-
modeling of nuclear DNA allows for tighter compaction and protects against mutation. 
Histones are the predominant protein binding genomic DNA in somatic cells, and they 
play this role in male germ cells as well up to the end of meiosis. However, spermatid 
elongation calls for the replacement of histones, first by transition proteins TP-1 and TP-2 
(Bedford and Calvin 1974; Balhorn, Weston et al. 1984), and ultimately by highly basic 
protamine proteins (Aitken and Krausz 2001; Aitken and Baker 2004). By binding to 
protamines, genomic DNA is remodeled to a toroid “doughnut-like” structure that is 
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resistant to the numerous stresses encountered during prolonged storage and journey to 
the oocyte (Toshimori 2009). 
 
Tail Formation 
Chromatin remodeling to create the unique structure of the sperm head allows for 
efficient and stable transport of haploid genomic material, accomplishing one of the 
primary structural goals of sperm development. Head shapes vary somewhat across 
species, being generally classified as: 1) sickle-shaped (falciform), common in rodents, 
and 2) paddle-shaped (spatulate), seen in humans and many other species (Inaba 2011). 
 
While there is some variation in the structure of the sperm head, evolution has more 
strongly shaped the spermatozoan tail. Transit of genomic material (i.e. the sperm head) 
within the female reproductive tract is the end goal of spermatogenesis, and the structure 
of eukaryotic sperm flagellum is remarkably conserved across species (Baccetti and 
Afzelius 1976), being a nearly universal approach to the challenge of male gamete 
motility (Oko 1988). 
 
Flagellum formation is based on the assembly of a cytoskeletal core, known as the 
axoneme, which supplies structure and coordinates movement. Surrounding the 
axoneme, robust mitochondrial development fuels waveform movement, while outer 
dense fibers (ODFs) and a fibrous sheath (FS) form accessory cytoskeletal components 
(Tesarik, Sousa et al. 1998). While ICSI has opened the door to fertilization using non-
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motile sperm (Pazour, Agrin et al. 2005), under normal conditions the building and 
maintenance of these flagellar structures is essential. 
 
Basic Research on Cilia & Flagella 
From a structural perspective, the terms ‘cilia’ and ‘flagella’ are used interchangeably. 
Function and formation have been so strongly conserved by evolution that these 
structures are eukaryotic life’s sole option for a directed, rapidly moveable cellular 
appendage. 
 
Strong conservation of cilia structure and components has allowed for significant 
molecular biology insight based on proteomic and gene mutation analyses in model 
organisms, most notably the unicellular algae Chlamydomonas reinhardtii (overview in 
(Lefebvre and Rosenbaum 1986)). The first critical ciliary genes were identified by 
investigation of proteins markedly up-regulated following biochemical removal of cilia – 
protein products produced after this disruption were hypothesized to be needed for 
replacement of the missing organelle (Luck, Huang et al. 1982; Blacque, Cevik et al. 
2008). From this initial set of candidate flagellar components, single-gene mutation 
studies have highlighted several genes that are critical to ciliary motility; gene mutations 
resulting in flagellar paralysis, misassembly within macromolecular complexes, or 
perturbed interactions between large cytoskeletal components have been reported. This 
extensive body of work (reviewed in (Wargo and Smith 2003)) has highlighted the 
importance of the “9 + 2” axoneme, the core cytoskeletal structure that gives shape to 
eukaryotic and allows for coordinated movement. 
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The “9 + 2” axoneme consists of a circular arrangement of 9 outer microtubule doublets 
surrounding two central, singlet microtubules dubbed the “central pair.” In 
Chlamydomonas, these singlet microtubules are designated “C1” and “C2,” and each 
possesses asymmetric projections to the surrounding doublets, allowing regulation of the 
outer microtubules’ sliding movements (Dutcher and Lux 1989). In addition, the central 
pair have direct connections to each other, allowing them to coordinate in their 
manipulation of the outer doublets. Critically, this central pair is not present in the “9 + 0” 
axoneme found in eukaryotic sensory, or “primary” cilia, and thus is deemed defining and 
essential to ciliary motility. 
 
Gene mutation and ultrastructural analyses in Chlamydomonas have allowed 
characterization of specific domains of the axoneme, such that proteins can be assigned 
in one of five groupings: 1) β-tubule projections, running between microtubules of a given 
doublet; 2) Outer dynein arms, which extend from one doublet towards another along the 
periphery of the axoneme; 3) Inner dynein arms, which extend from one doublet towards 
another along the medial portion of the axoneme; 4) Radial spokes, which extend from 
the outer doublets towards the central pair; 5) Central pair components, which facilitate 
connections within one microtubule or between the pair (Duldulao, Li et al. 2010). 
 
Ciliary dysfunction in disease 
While their functions are not yet fully understood, cilia are found on almost all mammalian 
cells (Nonaka, Tanaka et al. 1998; Nonaka, Shiratori et al. 2002). Though research 
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efforts have previously examined ciliary functions in organisms such as Chlamydomonas 
due to the relative simplicity of biochemical manipulations in such models, recent work 
has focused more strongly on mammalian pathologies and development. It has been 
shown that cilia in mice are essential for proper left-right asymmetry during embryonic 
development (Chizhikov, Davenport et al. 2007; Davenport, Watts et al. 2007; Haycraft, 
Zhang et al. 2007; Lehman, Laag et al. 2009; McDermott, Liu et al. 2010). The advent of 
Cre-Lox conditional gene knockout technology has enabled targeted probing of ciliary 
function in particular cell types, leading to the discovery of ciliary involvement in functions 
such as hair follicle development, bone formation, mammary gland branching, central 
nervous system morphogenesis, and satiety responses (Huangfu, Liu et al. 2003). These 
somewhat unexpected observations have generated significant interest in the roles cilia 
play not only as structural organelles but also as components of signal transduction. The 
vertebrate Hedgehog pathway, which governs gene expression during development, is 
dependent on cilia (Otto, Schermer et al. 2003; Simons, Gloy et al. 2005). Wnt signaling 
is also affected by cilia function, thought in part due to the fact that the Wnt master switch 
Inversin localizes to cilia (Hildebrandt, Benzing et al. 2011). 
 
In humans, cilia have been associated with a numerous diseases, collectively termed 
ciliopathies. The ubiquity of cilia expression suggests that cilia function is important in a 
wide variety of cell types and tissues, though we will focus here on several important 
examples (for a full review see (Wodehouse, Kharitonov et al. 2003; Olin, Burns et al. 
2011)). 
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Primary Ciliary Dyskinesia/Kartagener’s Syndrome 
Primary Ciliary Dyskinesia (PCD) often manifests immediately in affected neonates, 
reflecting that it is a disorder with origins during embryonic development. However, 
diagnosis requires identification of a complex clinical presentation and subsequent TEM 
(transmission electron microscopy) analysis of the patient’s cilia, making it likely that at 
least some patients are missed and do not receive treatment (Zhu, Belmont et al. 2006). 
Diagnosed by electron microscopy evidence of specific ciliary ultrastructural defects or 
genetic testing revealing mutation in one of eight known genes, PCD has a somewhat 
variable presentation centered around a trio of classic symptoms. Ciliary dysmotility 
during embryogenesis commonly leads to situs inversus – complete left-right asymmetry 
of the visceral organs – without apparent consequence. 50% of PCD patients have situs 
inversus without observed clinical sequelae, while 6% have heterotaxy, abnormal 
distribution of the viscera with paired organs (e.g. lungs, kidneys) mirrored rather than 
uniquely “left” or “right” (Noone, Leigh et al. 2004; Kendig and Wilmott 2006). The most 
common clinical symptom is severe respiratory distress, requiring neonatal oxygen 
supplementation and leading to chronic respiratory infection. Ciliary defects lead to 
reduced mucus clearance, creating a fertile ground for these repeated bacterial 
infections. In adulthood, these early problems generally lead to bronchiectasis, a dilation 
of the bronchial tree where constant inflammation limits airway adaptability, as in COPD 
commonly suffered by long-term cigarette smokers (Afzelius 2004). Male PCD patients 
additionally suffer from infertility in 50% of cases, owing to similar ultrastructural defects 
in the sperm flagellum (Saeki, Kondo et al. 1984). 
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Polycystic Kidney Disease 
A strong association between cilia and Polycystic Kidney Disease (PKD) has been known 
for decades (Yoder, Hou et al. 2002; Lin, Hiesberger et al. 2003; Otto, Schermer et al. 
2003), with many PKD-related genes isolated to cilia (Torres, Harris et al. 2007). PKD 
may result from autosomal dominant (AD) or recessive (AR) mutations, with the 
autosomal dominant forms representing the most common lethal autosomal dominant 
mutations in the US, at 1 in 1000 people affected (Pazour, Dickert et al. 2000; Yoder, 
Hou et al. 2002; Sun, Amsterdam et al. 2004). The genes affected in AD PKD, PKD1 and 
PKD2, are both important in differentiation and maintenance of renal tubules. Disruption 
of these genes, and of cilia-related genes within the kidneys in general, leads inevitably 
to kidney cyst formation (Kim and Walz 2007; Torres, Harris et al. 2007). These 
pathological changes are not always detected in youth, as their clinical manifestations – 
hypertension, abdominal pain, urinary tract infections – are non-specific (Alam and 
Perrone 2010; Hogan and Norby 2010). Without treatment, however, PKD leads to end-
stage renal disease requiring dialysis and eventual kidney transplant, an outcome that 
can be at least postponed with early detection and treatment (Ibanez-Tallon, Gorokhova 
et al. 2002; Sapiro, Kostetskii et al. 2002; Banizs, Pike et al. 2005). 
 
Hydrocephalus 
Hydrocephalus is a pathological accumulation of cerebrospinal fluid within brain’s 
ventricular spaces. Under normal conditions, cerebrospinal fluid is constantly moved, 
resorbed and processed by ependymal cells, which form a ciliated epithelium 
surrounding the ventricles. When ependymal cilia are unable to perform this task, fluid 
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builds up within the ventricular spaces and forces expansion, compressing cerebral 
tissue and raising intra-cranial pressure to unsafe levels (Inaba 2011).  
 
The diversity of clinical pathologies deriving from cilia dysfunction demonstrates the 
complexity of roles played by cilia in the human body. Addressing these clinical 
challenges requires a better understanding of the basic molecular biology of the highly 
conserved ciliary structure. 
 
Spag16 and the Axoneme 
The studies discussed here will focus primarily on a gene of the axoneme’s central 
apparatus. The central apparatus contains at least 17 proteins (Randall, Warr et al. 1964; 
McVittie 1972; Adams, Huang et al. 1981; Dutcher, Huang et al. 1984; Brokaw and Luck 
1985), including products from six of the ‘pf’ genes, so designated because their loss in 
Chlamydomonas reinhardtii results in paralyzed flagella: pf6, pf15, pf16, pf18, pf19, and 
pf20 (Xu and Min 2011). 
 
SPAG16, homologous to pf20 found in Chlamydomonas, produces a 631 amino acid 
protein. The only identified conserved domains in the SPAG16 protein are seven WD-
repeat domains located on the C-terminal half. These WD domains of approximately 40 
amino acids in length give rise to a tertiary beta propeller structure, and are thought to 
mediate macromolecular assembly through protein-protein interactions (reviewed in 
(Zhang, Sapiro et al. 2002)). In all studied eukaryotic organisms, the pattern of protein 
structure and function is highly conserved: the protein is located exclusively in the 
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cytoplasm of ciliated cells, and specifically is found in the axoneme central apparatus; the 
amino acid sequence is comprised of an N-terminal half with no known conserved 
domains, and a C-terminal half with seven WD repeats. 
 
In mice, the classic Spag16 protein product is known as SPAG16L, or “long” SPAG16, as 
a second, shorter protein product has been identified and labeled SPAG16S (Strausberg, 
Feingold et al. 2002). Whereas SPAG16L is found in all ciliated cells, SPAG16S was 
isolated from testis, and has not been detected in any tissue outside the male 
reproductive system to date. The amino acid sequences in both proteins are exactly the 
same, except that SPAG16S lacks the N-terminal half of SPAG16L, having instead only 
the portion with WD repeats. Unlike SPAG16L, SPAG16S is found in the nucleus (as well 
as the cytoplasm), and is enriched in specific sub-nuclear clusters. 
 
While SPAG16S has been most extensively characterized in mice, including the work 
presented here, we hypothesize that expression of SPAG16S represents an evolution of 
the Spag16 gene in mammals. We have previously identified a putative SPAG16S 
promoter and 5’-UTR in humans [GenBank: EF591776.1], and the identified rat version of 
SPAG16 – isolated from testis – resembles murine SPAG16S (Clark 2007).  
 
Phenotypes of Spag16 disruption 
Though it has been one of the major goals of the field of male reproduction research for 
decades, a reliable male germ cell model line has yet to be established (reviewed in 
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(Zhang, Kostetskii et al. 2006)). As a result, studies of gene function are largely carried 
out using transgenic mouse models. 
 
SPAG16L 
We have previously reported that male mice with a gene mutation disrupting production 
of SPAG16L (but not SPAG16S) are infertile, with reduced sperm counts and profound 
disruption of sperm motility, demonstrating the importance of SPAG16L to sperm flagellar 
function (Lesich, Zhang et al. 2010). Interestingly, SPAG16L-deficient mice do not display 
signs of hydrocephalus, bronchial abnormality, or kidney function failure. Additionally, the 
axoneme ultrastructure of SPAG16L-deficient mice appears normal when examined by 
transmission electron microscopy. However, recent studies have demonstrated that 
sperm flagella from SPAG16L-deficient mice show greatly reduced bending during 
attempted waveform movement, and that molecular responses to calcium are 
significantly diminished (Zhang, Kostetskii et al. 2004). In light of these recent data, we 
hypothesize that the role of SPAG16L in the axoneme is essential for coordinated 
movement within the structure, rather than for structural assembly. The critical point, 
however, is that loss of SPAG16L specifically affects flagellar motility, whereas 
spermatogenesis is largely undisturbed. 
 
SPAG16L and SPAG16S 
Disruption of both isoforms of SPAG16 results in a severe phenotype that manifests even 
in the chimeric state of transgenic animal breeding: spermatogenesis is significantly 
disrupted, and the flagellar axoneme is significantly disrupted (Zhang, Kostetskii et al. 
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2004). Notably, the Spag16 mutant transgene was never transmitted by fertile male 
carriers, suggesting that sperm carrying the mutant copy of the gene were unable to 
complete spermatogenesis and/or fertilize a female ovum. Haploinsufficiency is rarely 
encountered in male reproduction, as such profound defects are unable to be passed to 
offspring and thus do not remain in the population. The difference between the flagellar-
specific disruption seen with loss of SPAG16L alone and the spermatogenetic arrest 
observed with disruption of both isoforms suggests a fundamental role for Spag16 in 
sperm development and function. We hypothesize that the localization of SPAG16S in 
the nucleus is necessary for the coordination of molecular signals that direct the progress 
of spermatogenesis. 
 
SPAG16 protein interactors 
As SPAG16 proteins lack identifiable effector domains, they are believed to function 
through interaction with other proteins, likely through the assembly of macromolecular 
complexes. We have previously reported that SPAG16S interacts with MEIG1, a 10-kDa 
protein initially believed to play a role in regulation of meiosis (Zhang, Shen et al. 2009). 
We have recently found that male mice deficient in MEIG1 are infertile due to arrest of 
spermatogenesis at the stages of elongation and condensation (Salzberg, Eldar et al. 
2010), a conclusion which has been reached by an independent group as well 
(Stirnimann, Petsalaki et al. 2010). While the mechanism for spermatogenesis arrest in 
the absence of MEIG1 cannot be conclusively linked to SPAG16S, this finding provides 
additional support for the hypothesis that a SPAG16S-related pathway is necessary to 
spermatogenesis and independent of the structural role of SPAG16L. 
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Both SPAG16S and SPAG16L most likely exert their influence through interaction with 
several different effector partners. WD domains have been referred to as among the 
most promiscuous interactors (Lau, Bachorik et al. 2009), as they are commonly 
retrieved candidates in protein interaction studies. Further, it has recently been reported 
that at least some WD domains confer RNA binding specificity as well (Luck 1984; Porter 
and Sale 2000). The diversity of potential interaction partners means that relatively little is 
known about the evolution and function of the SPAG16 gene.  
 
The present work will discuss the roles of SPAG16 in mammals by examining: the sub-
localization of murine SPAG16S; the functional roles of the SPAG16S protein; the status 
of the SPAG16 gene in azoospermic human subjects. 
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Chapter 2:  Spag16, an Axonemal Central Apparatus Gene, Encodes a Male Germ 
Cell Nuclear Speckle Protein that Regulates SPAG16 mRNA Expression 
 
Abstract 
Spag16 is the murine orthologue of Chlamydomonas reinhardtii PF20, a protein known to 
be essential to the structure and function of the “9 + 2” axoneme. In Chlamydomonas, the 
PF20 gene encodes a single protein present in the central pair of the axoneme. Loss of 
PF20 prevents central pair assembly/integrity and results in flagellar paralysis. Here we 
demonstrate that the murine Spag16 gene encodes two proteins: 71 kDa SPAG16L, 
which is found in all murine cells with motile cilia or flagella, and 35 kDa SPAG16S, 
representing the C terminus of SPAG16L, which is expressed only in male germ cells, 
and is predominantly found in specific regions within the nucleus that also contain SC35, 
a known marker of nuclear speckles enriched in pre-mRNA splicing factors. SPAG16S 
expression precedes expression of SPAG16L. Mice homozygous for a knockout of 
SPAG16L alone are infertile, but show no abnormalities in spermatogenesis. Mice 
chimeric for a mutation deleting the transcripts for both SPAG16L and SPAG16S have a 
profound defect in spermatogenesis. We show here that transduction of SPAG16S into 
cultured dispersed mouse male germ cells and BEAS-2B human bronchial epithelial cells 
increases SPAG16L expression, but has no effect on the expression of several other 
axoneme components. We also demonstrate that the Spag16L promoter shows 
increased activity in the presence of SPAG16S. The distinct nuclear localization of 
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SPAG16S and its ability to modulate Spag16L mRNA expression suggest that SPAG16S 
plays an important role in the gene expression machinery of male germ cells. This is a 
unique example of a highly conserved axonemal protein gene that encodes two protein 
products with different functions. 
 
Introduction 
The “9+2” axoneme, a cytoskeletal structure found in motile cilia and flagella, is 
composed of nine outer doublet microtubules linked to a central microtubule pair via 
dynein arms to form a motor complex allowing coordinated force generation (Adams, 
Huang et al. 1981; Dutcher, Huang et al. 1984). The central pair of microtubules is critical 
to the integrity and the motility of this structure. One essential element of the central 
apparatus, PF20, was first identified in Chlamydomonas reinhardtii (Smith and Lefebvre 
1997; Smith and Lefebvre 1997), and has since been shown to exhibit strong 
conservation amongst a wide variety of organisms and ciliated cell types (Zhang, Sapiro 
et al. 2002). 
 
We have reported that the murine orthologue of PF20, Spag16, encodes two distinct 
proteins: SPAG16L, which is a component of the axoneme central apparatus (Zhang, 
Kostetskii et al. 2004),  and SPAG16S, a smaller protein representing the WD repeat 
region of SPAG16L, identified only in male germ cells (Zhang, Kostetskii et al. 2004). 
Chimeric mice carrying a mutation that disrupted the Spag16 gene at a locus shared by 
transcripts encoding both SPAG16L and SPAG16S displayed a phenotype of 
haploinsufficiency; the mutant allele was never transmitted to offspring by chimeric males 
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(Zhang, Kostetskii et al. 2006). Furthermore, these mice exhibited significant germ cell 
loss at the round spermatid stage. In contrast, transgenic mice homozygous for a 
deleterious mutation in the SPAG16L-specific region of the gene were infertile, with 
normal spermatogenesis but resulting in sperm showing marked motility defects despite 
an axonemal structure devoid of significant ultrastructural defects (Lamond and Spector 
2003). The deficits observed with ablation of both SPAG16 isoforms, not accounted for 
by loss of SPAG16L alone, suggest that SPAG16S may play a critical and previously un-
described role in spermatogenesis. 
 
We show here that SPAG16S is localized to nuclear subdomains called nuclear 
speckles.  Nuclear speckles are non-nucleolar domains within the nucleus that contain 
splicing factors as well as transcription factors, RNA processing units, and structural 
scaffold proteins (reviewed by Lamond and Spector (Ricciardi, Kilstrup-Nielsen et al. 
2009; Hu, Plutz et al. 2010)). Though not generally believed to be centers of active 
transcription, speckles have been implicated as compartments that can provide splicing 
factor contents to active transcription sites (Shopland, Johnson et al. 2003). Speckles are 
enriched in SC35, which is used as a marker for these distinct domains. SC35 domains 
have been linked to the development of a cell-type specific genomic organization and to 
the mapping of distinct “euchromatic neighborhoods” (Zhang, Kostetskii et al. 2006; 
Zhang, Zariwala et al. 2007). Though nuclear speckles have been shown to play central 
roles in management of gene expression, their role in male germ cell differentiation has 
not been previously reported. 
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Results 
Identification of the 5' UTR of mouse SPAG16S 
To identify the 5' UTR of Spag16S mRNA, 5' RACE was performed with a primer located 
close to the 3' end of mouse Spag16L mRNA (Fig. 2-1A). Two PCR products were 
amplified (Fig. 2-1B), and each one was cloned into the pCR2.1 Topo TA vector 
(Invitrogen). 10 clones of each PCR product were sequenced after vector insertion, 
demonstrating that Spag16S sequence is identical to that of Spag16L exons 11-17, with 
the addition of a 5' untranslated exon, not found in Spag16L, named exon 10a (Fig. 2-
1C). This exon 10a is located in the middle of intron 10 of the Spag16 gene, 
approximately 50 kb from Spag16L exon 10 and 50 kb from Spag16L exon 11. 
Sequencing results demonstrated multiple potential transcription start sites for Spag16S 
transcription; the exon is situated in a TC-rich locus that lacks a standard TATA box (Fig. 
2-10). 
 
Spag16S message is expressed only in the testis and male germ cells 
SPAG16L is present not only in testis, but also in other murine tissues containing cells 
with a “9 + 2” axoneme structure (Zhang, Kostetskii et al. 2004). Primer sets were 
designed to specifically amplify Spag16L (exons 2-4) or Spag16S (exons 10a-12) (Fig. 2-
1C). In adult mice, Spag16L mRNA was detected in testis, brain, lung, and oviduct; 
however, Spag16L mRNA was not detected in heart tissue (Fig. 2-1D), which does not 
contain cells with motile cilia. Spag16S mRNA was detected only in testis (Fig. 2-1D), 
and in further testing was not detected in kidney, liver, or spleen. Spag16S expression 
also appears to be exclusive to males, rather than being a general germ cell factor, as 
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Spag16S mRNA was never detected by PCR using up to 10 oocyte equivalents in qPCR 
amplification of up to 40 cycles. 
 
Expression pattern of SPAG16S during the first wave of spermatogenesis 
RNA and protein were isolated from mouse testis at 6, 8, 12, 16, 20, 30, and 42 days 
after birth. cDNA was generated by RT-PCR, and testis extracts were probed by PCR for 
Spag16 isoform expression using specific primers. Spag16S mRNA was detected at day 
16, whereas Spag16L mRNA was detected later, at day 20 (Fig. 2-2B). Western blotting 
was performed as well, using a polyclonal antibody that recognizes both isoforms of 
SPAG16 (Zhang, Shen et al. 2008). Consistent with PCR results, SPAG16S protein was 
detected at day 16, while SPAG16L was detected at day 20 (Fig. 2-2C). Additionally, 
both isoforms appeared to be up-regulated at days 30 and 42, consistent with the end of 
the first wave of spermatogenesis.  The immunoreactive bands other than 71 kDa 
SPAG16L and 35 kDA SPAG16S seen on days 20, 30 and 42 may represent post-
translational processing of SPAG16, including proteolytic cleavage of SPAG16L and 
phosphorylation or other modifications (Smith and Lefebvre 1997; Zhang, Tang et al. 
2007; Lesich, Zhang et al. 2010). 
 
Sub-cellular localization of SPAG16 isoforms 
Cytoplasmic and nuclear fractions of adult mouse testis were isolated, and equivalent 
amounts of protein from each were probed by Western blot using the C-terminal SPAG16 
antibody that recognizes both isoforms. SPAG16L was detected abundantly in the 
cytoplasm, while SPAG16S was detected in both cytoplasm and nucleus (Fig. 2-3A). The 
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cytoplasmic localization of SPAG16L is consistent with its identified role as a structural 
component of the “9 + 2” axoneme (Zhang, Kostetskii et al. 2006). In order to further 
characterize the sub-cellular localization of SPAG16S, immunohistochemistry was 
performed on tissue slices from adult mouse testis. Using the C-terminal SPAG16 
antibody, the strongest signal was detected from discrete structures within the nucleus 
(Fig. 2-3B, see arrows). Protein expression was most clearly visualized approximately 
halfway through spermatogenesis, at the round spermatid stage.  
 
A mixed population of mouse male germ cells was prepared from adult mouse testis, and 
immunocytochemistry performed to allow for single-cell imaging to compare with 
immunohistochemistry results. Consistent with previous data, the C-terminal SPAG16 
antibody produced the strongest fluorescence in discrete sub-nuclear, non-nucleolar 
structures, approximately 2-6 per cell (Fig. 2-4). The N-terminal SPAG16 antibody, 
recognizing SPAG16L only, produced an exclusively cytoplasmic signal. Germ cells from 
SPAG16L-KO mice (Bastin, Pullen et al. 2000; Kohl and Bastin 2005) were isolated and 
immunolabeled as well, demonstrating the specificity of the antibodies (Fig. 2-4). As in 
wild-type germ cells, the C-terminal SPAG16 antibody produced sub-nuclear 
immunolabelling, which we interpret to represent SPAG16S, while the N-terminal 
antibody produced no signal, as expected following the deletion of SPAG16L. 
 
SPAG16S co-localizes with nuclear speckles 
In order to characterize the discrete nuclear structures identified by immunohistochemical 
analysis of SPAG16S localization, wild-type germ cells were co-immunolabeled with both 
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the C-terminal SPAG16 antibody and a monoclonal antibody directed against SC35, a 
marker for nuclear speckles. SC35 and SPAG16S signals strongly overlapped (Fig. 2-
5A). They were determined to have a significant co-localization (Fig. 2-5B – Pearson's 
coefficient = 0.40; p = 0.0079; N  = 43). Analysis demonstrated that 79% of SC35 signal 
co-localized with SPAG16S, while 44% of SPAG16S signal co-localized with SC35; in 
other words, most SC35-containing domains also contained SPAG16S, but SPAG16S 
had a wider distribution as well. 
 
Role of SPAG16S in SPAG16L expression 
Given the timing of SPAG16S expression (Fig. 2-2B-C) and its specific nuclear 
localization (Fig. 2-3 – 2-5), it was hypothesized that SPAG16S might play a role in 
regulation of gene expression. Mixed mouse male germ cells were isolated from testis 
and cultured, with exposure to a SPAG16S-transducing adenovirus or a control 
adenovirus. Following 48 hour culture, RNA was isolated for analysis of gene expression, 
and several highly conserved axoneme genes were assessed for mRNA levels. While 
Spag6, Spag17, and Akap4 were unaffected, Spag16L message level was significantly 
increased (Fig. 2-6). 
 
SPAG16S was also shown to induce SPAG16L expression in BEAS-2B human bronchial 
epithelial cells. This cell line does not express SPAG16L at levels detectable by qPCR or 
Western blotting (data not shown). Expression of SPAG16S was induced in cultured 
BEAS-2B cells by plasmid (Fig. 2-7A) or adenovirus (Fig. 2-7B), and primers specific for 
human SPAG16L were used to measure transcript levels, which were normalized to 18S 
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rRNA. Immunocytochemistry performed with the C-terminal SPAG16 antibody confirms 
that SPAG16 proteins are expressed in the transduced cells, but not in cells exposed to a 
control adenovirus (Fig. 2-7C). Following adenoviral transduction, protein was also 
isolated from cultured BEAS-2B cells, and SPAG16L was demonstrated by Western blot 
to be present in cells transduced with SPAG16S adenovirus, but not cells transduced 
with a control adenovirus (Fig. 2-7D). 
 
Following the observation that SPAG16L protein and mRNA levels were increased in the 
presence of SPAG16S, Spag16L promoter activity was tested as well. While other 
axoneme gene promoters (Spag17, Spag6) did not show significantly altered activity, 
SPAG16L promoter activity was significantly higher in the presence of plasmid-induced 
SPAG16S when compared to co-transfection with a control empty vector plasmid (Fig. 2-
8).  
 
In order to identify a specific region within the SPAG16L promoter showing increased 
activity with SPAG16S expression, luciferase plasmid constructs were made with 
progressively shorter sequences of the SPAG16L proximal promoter, ranging from 2 kb 
to 100 bp upstream of the transcription start site. Promoters ranging from 2 kb to 200 bp 
upstream of the transcription start site demonstrated significantly higher activity when co-
transfected with a SPAG16S plasmid, but a 100 bp upstream SPAG16L promoter did not 
show increased activity in the presence of SPAG16S plasmid (Fig. 2-9).  
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Discussion 
Flagella and cilia are strongly conserved structures, having maintained a highly specific 
structure and function throughout eukaryotic life, from unicellular protists to mammals 
(Inaba 2003; Inaba 2007). It has been suggested that molecular structures of each 
component in the axoneme are not always conserved, but protein domains within 
axoneme structures are preferably conserved, allowing for overall morphological and 
functional conservation (Kleene 1996; Fajardo, Haugen et al. 1997). Although the 
Chlamydomonas pf20 gene encodes only one transcript, its mouse orthologue encodes 
two mRNAs for two proteins, SPAG16L and SPAG16S, each of which have conserved 
WD-repeat domains. To study the expression pattern of the two mRNAs and proteins, 
testicular total RNAs and proteins were isolated from mice at different ages. Given that 
Spag16S harbors an untranslated exon 10a – which is not present in Spag16L – a 
Spag16S-specific forward primer was designed to selectively amplify the Spag16S 
transcript. Both SPAG16S mRNA and protein are expressed earlier than SPAG16L 
message and SPAG16L protein. For both SPAG16L and SPAG16S, mRNAs and 
proteins appear simultaneously (SPAG16S at day 16, followed by SPAG16L at day 20), 
suggesting that there is no translation delay (Zhang, Tang et al. 2007). Furthermore, 
Spag16L is expressed in other tissues, such as brain and lung, all of which contain motile 
cilia (Reddi, Flickinger et al. 1999; Eddy 2002; Reddi, Shore et al. 2002), but Spag16S is 
expressed only in the mouse testis, indicating that Spag16S is a testis-specific gene 
product. Moreover, Spag16S sequences identified in GenBank in a variety of mammalian 
species (Mouse: NM_025728.3; Rat: BC158602.1; Human: EF591776.1) have each 
been detected from testis samples. 
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Testis-specific genes can be grouped into three clusters. Homologous genes are those 
which are expressed only in spermatogenic cells, but which are closely related to genes 
expressed in somatic cells, and are often members of gene families. Unique genes are 
those without significant similarity to any other genes in the genome. Variant transcripts 
are transcribed from genes also expressed in somatic cells but are often smaller or larger 
than their somatic cell counterparts. They are the result of the utilization of one or more 
alternate transcriptional start sites, splice sites, or polyadenylation signals. Since 
spermatogenesis is a highly coordinated process, different genes are expressed during 
the three different stages of spermatogenesis, and gene expression can be used as a 
tool to assess progression through the stages of spermatogenesis (Wang, McCarrey et 
al. 2001). There are genes that have been shown to be expressed solely in the mitotic 
phase (spermatogonia) (Eddy and O'Brien 1998). Some are expressed during the meiotic 
phase (spermatocyte) (Beissbarth, Borisevich et al. 2003) and others during the post-
meiotic phase in spermatids (Zhang, Kostetskii et al. 2006). Some of these genes are 
expressed solely in germ cells, while others are also expressed in somatic cells as well. 
 
It appears that the Spag16S transcript is unique, as no related transcripts were identified 
in somatic cells. It is unlikely to be a spliced isoform of the Spag16L transcript, since it is 
detected in testis of mice homozygous for a mutation that ablates the Spag16L mRNA 
(Strausberg, Feingold et al. 2002). Similarly, evidence suggests that the SPAG16S 
protein is not a processed form of SPAG16L, since the SPAG16S protein is present in 
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SPAG16L-deficient mice, and the expression of SPAG16S occurs earlier than SPAG16L 
(Figure 2-2). 
 
The mouse Spag16S 5’-UTR and upstream putative promoter region are highly 
conserved in rat (see Fig. 2-10). It is worth noting that only a single Spag16 transcript has 
been identified in rat (BC158602.1), and its coding sequence corresponds to the region 
shared by both mouse Spag16 isoforms. However, the rat Spag16 mRNA includes a 410 
bp 5’-UTR that is nearly identical to the mouse exon 10a plus its immediate upstream 
genomic sequence (Zhang, Kostetskii et al. 2006). Moreover the rat Spag16 transcript 
was identified specifically in testis, leaving open the possibility that a Spag16L-like 
transcript may be likely to exist in testis and other tissues. 
 
Different subcellular localization of SPAG16L and SPAG16S suggests that the two 
proteins play different roles. This was subsequently confirmed by two knockout models 
generated previously in our laboratory. SPAG16L regulates ciliary motility (Zhang, 
Kostetskii et al. 2004), while SPAG16S controls spermatogenesis (Escalier 2006). Loss 
of both SPAG16 isoforms produced a non-transmitted allele and led to significant arrest 
and cell death at the round spermatid stage in chimeric male mice carrying the mutant 
gene. While homozygosity for a SPAG16L-deletion mutation produced male infertility, the 
mutant allele was transmitted in the chimeric and heterozygous states, and the 
perturbation of spermatogenesis observed with total SPAG16 knockout was not seen. It 
has been observed that genetic mutations contributing to male infertility are often 
discovered to take effect through unexpected or unexplored cellular pathways. Thus, 
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while Spag16 is known to be important to the axoneme through SPAG16L, the existence 
of an additional protein of unknown – and potentially more essential – function is 
consistent with published findings (Neer, Schmidt et al. 1994; Smith, Gaitatzes et al. 
1999). 
 
Both SPAG16L and SPAG16S contain 7 WD-repeat domains, semi-conserved 40 amino 
acid-regions ending with tryptophan-aspartate (W-D). These regions are known to 
mediate protein-protein interactions by giving rise to a ß–propeller tertiary structure. By 
interacting with effector partners, WD repeat proteins have been shown to play important 
roles in an extensive variety of cellular activities, including cell division, gene 
transcription, mRNA modification, and transmembrane signaling (reviewed in 
(Gallenberger, Meinel et al. 2011)). More recently, it has been reported that WD domains 
may also mediate specific processing of small RNAs (Lau, Bachorik et al. 2009) and 
direct binding of RNAs (Caceres, Misteli et al. 1997; Lallena and Correas 1997), further 
diversifying the range of potential roles these structures can play in eukaryotic cells.  
Because SPAG16S contains no obvious nuclear localization signals, its importation into 
the nucleus may be effected by its association with other proteins including transcription 
factors or nuclear speckle components. 
 
We have demonstrated that while SPAG16L is exclusively in the cytoplasm of male germ 
cells – consistent with its structural role in the axoneme – SPAG16S is present in both 
nucleus and cytoplasm, and exhibits enhanced sub-localization within the nucleus. A 
monoclonal antibody directed against SC35, a canonical marker for nuclear speckles 
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(Lamond and Spector 2003), maps to the same nuclear regions that show enhanced 
SPAG16S signal, suggesting that SPAG16S is located in nuclear speckles of male germ 
cells, specifically at the round spermatid stage. Nuclear speckles are enriched in splicing-
related factors, and though they are not active centers of transcription (Brown, Green et 
al. 2008; Hu, Kwon et al. 2008; Takizawa, Gudla et al. 2008; Zhao, Bodnar et al. 2009), 
they have been shown to associate with active alleles (Spector, O'Keefe et al. 1993).  
 
The role of nuclear speckles has yet to be described in mammalian spermatogenesis. 
Though somatic cells nuclei contain 30-50 nuclear speckles, these structures are known 
to condense following inhibition of transcription (Marchler-Bauer and Bryant 2004; 
Marchler-Bauer, Lu et al. 2009); thus, the presence of only a few, larger speckles at the 
round spermatid stage is consistent with the down-regulation of transcription during 
sperm development. The unique nature of transcript and protein packaging during 
nuclear condensation in spermatogenesis suggests the intriguing possibility that nuclear 
speckles may play a distinct role in this process, and that SPAG16S may be a germ cell-
specific factor necessary to guide this process. 
 
SPAG16L mRNA and SPAG16L protein are up-regulated in vitro in the presence of 
SPAG16S, suggesting that one role of SPAG16S involves regulation of the SPAG16L 
isoform. These data are consistent with the observation that SPAG16L appears after 
SPAG16S. We have also shown that the Spag16L promoter displays significantly 
enhanced activity in the presence of SPAG16S. 
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While we cannot rule out the possibility that SPAG16S is involved in SPAG16L regulation 
through transcript processing events in nuclear speckles, these data strongly suggest 
that a primary responsibility of SPAG16S is activation of SPAG16L transcription. Since 
SPAG16S does not have an identified DNA-binding domain, it is unlikely to directly bind 
the Spag16L promoter, but rather to effect this interaction by binding with one or several 
protein partners. WD-repeat proteins are known to interact dynamically and reversibly 
with multi-protein complexes, thus identification of SPAG16S-associating structures 
presents a challenging but enticing area for future study. 
 
While the in vitro promoter studies presented here strongly suggest a role for SPAG16S 
in direct transcription of SPAG16L, future studies should seek to clarify the exact role of 
SPAG16S in male germ cell transcript regulation, as the speckle localization of the 
protein is more suggestive of a role in transcript processing.  Such studies would also 
clarify the role of nuclear speckles in round spermatids, as these structures are of 
particular interest given the unique transcriptional requirements of round spermatids as 
spermiogenesis takes place. 
 
The 2kb SPAG16L proximal promoter was also assessed for putative binding sites of 
other transcription factors using ConSite open source software, but current transcription 
factor lists are limited in scope, particularly regarding germ cell-specific relevant 
transcription factors, some of which are known to activate the SPAG16L promoter. Given 
currently limited in silico capabilities, we believe that further molecular data are required 
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before generalized transcription factor prediction is a sufficiently reliable in a germ cell 
system. 
 
In summary, SPAG16S is a testis-specific protein found in nuclear speckles that appears 
to regulate spermatogenesis by controlling testis-specific target gene expression, one of 
the target genes being Spag16L. Thus, the murine Spag16 gene has dual functions. It 
encodes a structural protein at the axoneme, which is essential for sperm motility, and a 
nuclear speckle-associated factor that regulates Spag16L gene expression. To the best 
of our knowledge, this is the first example of a gene’s evolution conferring the ability to 
regulate its own, conserved products. 
 
Materials and Methods 
Ethics Statement 
No human or primate subjects were used in this work. All rodent work was approved by 
Virginia Commonwealth University’s Institutional Animal Care & Use Committee (protocol 
permit #AM10297) in concordance with all federal and local regulations regarding the use 
of non-primate vertebrates in scientific research.  Research animals were humanely 
housed and care was taken to prevent undue distress. 
 
5’ Rapid amplification of cDNA ends (5’ RACE) 
5’ RACE was carried out to define the 5’ non-translated region sequence and 
transcriptional start site of the mouse Spag16S mRNA using mouse Marathon cDNA 
amplification kit (Clontech) according to the manufacturer’ instructions. Briefly, a reverse 
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primer was designed within the coding region of Spag16 (5’-
AGAAGCCACGAAGTCACCACAGGAGT-3’) and used together with the Marathon cDNA 
adaptor primer to generate 5’-RACE products. The smaller product was cloned into the 
pCR2.1-TOPO TA vector and subjected to DNA sequence analysis.  
 
Conserved domain analysis 
Mouse SPAG16S (NP_080004.1) and SPAG16L (NP_083436.2) protein sequences were 
analyzed using NCBI Conserved Domains tool (Zhang, Sapiro et al. 2002; Zhang, 
Kostetskii et al. 2004). 
 
Antibodies 
SPAG16-specific antibodies directed against the common C-terminus (SPAG16L amino 
acids 330-639) and the SPAG16L-specific N-terminus (amino acids 1-212) have been 
previously described (Abramoff, Magelhaes et al. 2004). -tubulin (cytoplasmic marker) 
and Lamin B (nuclear marker) were from Santa Cruz Biotechnology. SC35 was 
purchased from Sigma-Aldrich.  
 
Microscopy and colocalization analysis 
Confocal laser scanning microscopy was performed using a Leica TCS-SP2 AOBS 
(Leica Microsystems). Colocalization calculations were performed using Volocity 
Quantitation software (Perkin-Elmer). 
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Mixed germ cell preparation 
A male adult mouse was anesthetized and euthanized, and the testis decapsulated and 
placed in 5 mL PBS. Collagenase IV (Sigma-Aldrich) was added to a final concentration 
of 0.5 mg/mL and DNase I (Sigma-Aldrich) to a final concentration of 1.0 mg/mL. Testis 
solution was incubated 30 min at 32° C to dissociate cells, and then centrifuged 5 min at 
1000 rpm. Cells were fixed by 15 min incubation in 1% paraformaldehyde/PBS at room 
temperature, and then washed three times with PBS. Prior to plating, cells were re-
suspended in 12.5 mL PBS and 50 µL of cell suspension was spread on SuperFrost/Plus 
microscope slides (Fisher Scientific) and allowed to air-dry. Slides were used 
immediately for immunocytochemistry or stored at -80° C until use. 
 
Cell fractionation into nuclei and cytoplasm  
Freshly isolated mouse male germ cells (see germ cell slide preparation protocol) were 
separated into nuclear and cytoplasmic fractions using a Nuclear/Cytosol Fractionation 
Kit (BioLine, Inc.) per manufacturer’s instructions. 
 
Western blotting analysis  
Equal amounts of protein (50 µg/lane) were heated to 95° C for 10 minutes in 4X sample 
buffer, loaded onto 10% sodium dodecyl sulfate-polyacrylamide gels, electrophoretically 
separated, and transferred to PVDF membranes. The membranes were blocked and 
then incubated with primary antibody at 4° C overnight. After being washed, the blots 
were incubated appropriate HRP-conjugated secondary antibody (GE Healthcare UK) for 
1 hour at room temperature. After washing, protein was detected with Super Signal 
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Chemiluminescent Substrate (Pierce). Densitometry performed using ImageJ (Horowitz, 
Zhang et al. 2005) 
 
Immunocytochemistry and immunohistochemistry 
Slides were first blocked 1 hour at room temperature with 10% goat serum/PBS. 
Following overnight incubation with primary antibody (diluted 1:100-300 in blocking 
medium) at 4º C, slides were washed with PBS and incubated 1 hour at room 
temperature with Alex 488-conjugated anti-mouse IgG secondary antibody (1:500; 
Jackson ImmunoResearch Laboratories) or Cy3-conjugated anti-rabbit IgG secondary 
antibody (1:1000; Jackson ImmunoResearch Laboratories). Following secondary 
antibody incubation, slides were washed in PBS and sealed using VectaMount with DAPI 
(Vector Laboratories). 
 
Generation of adenovirus to express SPAG16S 
Adenovirus expressing SPAG16S (AdSpag16s) was generated with AdEasyTM 
Adenoviral Vector System (Stratagene) following the instruction manual. Briefly, mouse 
Spag16S cDNA was subcloned into adenovirus shuttle vector pShuttle-CMV and the 
cDNA was transferred into pAdEasy-1 virus genome by means of homologous 
recombination in an adenovirus packaging cell line HEK-293 cells (ATCC; Manassas, 
VA). The expression of SPAG16S was tested with western blotting using proteins from 
COS-1 cells (ATCC) and BEAS-2B cells (ATCC) infected with AdSpag16S or control Ad 
virus. The AdSpag16S and control Ad virus were amplified and titered in the 
Macromolecule Core Facility of Virginia Commonwealth University. 
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Generation of plasmid to express SPAG16S 
Mouse testis cDNA was used as a template to amplify Spag16S sequence by PCR. 
Amplified PCR product was cloned in a pCR2.1 Topo TA vector for sequencing, then 
released by restriction enzyme digestion and ligated in a pTarget vector. Primers used: 
Forward (BamHI): 5’-GGATCCCCTGTAGATATGCAACCAGATCC-3’; Reverse (SalI): 5’-
GTCGAC GCTGATCAGATCCACAACCGAATG-3’ 
 
RT-PCR and real-time PCR 
Total RNA was isolated from cultured cells and indicated tissues with Trizol (Life 
Technologies, Inc., Grand Island, N.Y.), the RNA was reversed transcribed, and the 
cDNAs were used for RT-PCR or real-time PCR. 
 
For real-time PCR, cDNAs from BEAS-2B cells transfected with pcDNA3 or 
Spag16S/pcDNA3 plasmids or infected with AdSpag16S or control Ad virus were utilized 
for PCR. Primers were designed for detection of human SPAG16L using the software 
from GeneScript Corporation (http://www.genscript.com/). Real-time PCR reactions were 
carried out using the 2X SYBR green master mix (BioRad). Akap4, Spag17, and Spag6 
primers have been previously reported (Horowitz, Zhang et al. 2005). 
(human) SPAG16L – Forward: 5’-TTCAGACTGCTGCTTCCATC-3’; Reverse: 5’-
TCGCCTGTACATAGATCCCA-3’ 
(mouse) Spag16L – Forward: 5’-AGCAAGCCAGAGACATCCAT-3’; Reverse: 5’-
CCAGAAATCTTCCCAACAGC-3’ 
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(mouse) Spag16S – Forward: 5’-CTCTGACACAATGAGTATGG-3’ (exon 10a); Reverse: 
5’-CTACAGGAAATTCTGAATCC-3’ (exon 11) 
18S – Forward: 5’-GGCCCTGTAATTGGAATGAGTC-3’; Reverse: 5’-
CCAAGATCCAACTACGAGCTT-3’ 
 
Luciferase promoter activity assay 
Promoter plasmids were designed using a PGL3 basic vector (Promega). For each 
experiment, BEAS-2B cells were co-transfected with empty vector or promoter plasmid 
and a control (pTarget - Promega) or test (SPAG16S) plasmid using Fugene 6 
transfection reagent (Roche) then cultured 48 hours. Cells were lysed using 1X passive 
lysis buffer according to manufacturer’s instructions (Promega) and luciferase activity 
measured using freshly-prepared reagents. Data are represented as relative fold 
difference from PGL3 control promoter co-transfected with control pTarget vector 
plasmid. 
 
Generation of promoter constructs for promoter function assays 
Promoter sequences were amplified by PCR from mouse DNA and sub-cloned in a PGL3 
basic vector after sequences were confirmed by first cloning in a Topo Vector (Invitrogen) 
for sequence analysis. Primers were designed to specifically amplify regions upstream of 
the transcription start site (Fig. 2-9). 2 kb, 1.5 kb, and 0.5 kb promoter constructs were 
previously generated in our lab (Boivin, Bunting et al. 2007). 0.3 kb, 0.2 kb and 0.1 kb 
promoter constructs were generated as described using a common reverse primer (5’-
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CTCGAGGCTTGCAACTGCGGCCCCTCGGTGCC-3’) with the following forward 
primers: 
0.3 kb Spag16L –5’-GGTACCCGCAAGCAAGCAAGCAAGCAAGCAAGC-3’ 
0.2 kb Spag16L – 5’-GGTACCGGTTCTGGGCTTCAGGTCTGCAGTCC-3’ 
0.1 kb Spag16L – 5’-GGTACCCGCTTGACCGGGGCCTTTTGGTGC-3’ 
 
Statistical Analysis 
Statistical analyses were performed using Student-Newman-Keuls post-hoc analyses 
with a significance level of α = 0.05. 
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Figure 2-1. The murine Spag16 gene encodes two transcripts. Spag16L is 
expressed in all tissues with ciliated cells, while Spag16S is expressed only in 
testis 
(A) 5' RACE was performed with a primer as indicated. (B) Products of 5' RACE 
separated on 1% agarose gel. (C) Exon map of Spag16 transcripts, unfilled box 
indicating untranslated exon 10a present only in Spag16S. Arrows indicate primers 
used to amplify specifically Spag16L or Spag16S message. (D) Specific primer sets 
were used as indicated for PCR amplification of cDNA from adult mouse tissues: Testis 
(T), Brain (B), Lungs (Lu), Oviduct (Ov), Heart (H). 
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Figure 2-2. SPAG16isoforms have identical conserved domains. SPAG16S 
appears before SPAG16L during the first wave of mouse spermatogenesis 
(A) Alignment and conserved domain analysis of SPAG16L and SPAG16S proteins. 
RNA (B) and protein (C) were isolated from mouse testis at the indicated day (bottom 
row) after birth. (B) Specific primer sets were used to probe gene expression by PCR of 
cDNA. (C) Protein samples were separated by SDS-PAGE and probed by Western 
blotting with a C-terminal SPAG16 antibody that recognizes both SPAG16L (71 kDa 
band) and SPAG16S (35 kDa band). Additional bands are not specific. 
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Figure 2-3. SPAG16L is in the cytoplasm of male germ cells, SPAG16S is in both 
the nucleus and the cytoplasm 
(A) Cytoplasmic and nuclear fractions of adult mouse testis probed by Western blot for 
SPAG16 (C-terminal antibody recognizing both isoforms) or markers of cytoplasm (α-
tubulin) or nucleus (Lamin B). (B) Sections of adult mouse testis immunolabeled with 
SPAG16 C-terminal antibody or pre-immune serum (negative control). Arrows indicate 
sample nuclear regions of heightened SPAG16 antibody immunoreactivity. 
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Figure 2-4. SPAG16S shows enriched nuclear sub-localization 
Mixed male germ cells from wild-type or transgenic SPAG16L-KO mice 
immunolabeled with SPAG16 antibodies (red; N-terminal = SPAG16L only, C-
terminal = both isoforms) and nuclear-stained with DAPI (blue). Pre-immune serum 
for each antibody is included as a negative control. 
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Figure 2-5. SPAG16S co-localizes with SC35 in nuclear speckles of mouse male 
germ cells 
(A) Mixed male germ cells immunolabeled for SC35 (green) or SPAG16 (red), with 
DAPI as a nuclear marker. (B) Co-localization analysis of SC35 + SPAG16, n = 43. 
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Figure 2-6. Transduction of SPAG16S induces SPAG16L expression in cultured 
mouse male germ cells 
Isolated adult mouse male germ cells were infected with an adenovirus causing 
SPAG16S transduction or a control adenovirus. Following 48 hours in culture, RNA was 
isolated and relative expression levels of indicated transcripts were measured. (* p<0.05 
compared with Ad/Control) 
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Figure 2-7. SPAG16S stimulates Spag16L mRNA and SPAG16L protein 
expression in BEAS-2B cells 
Analysis of Spag16L mRNA expression by real-time PCR in BEAS-2B cells stably 
expressing SPAG16S (A) or transduced with Ad/SPAG16S (B). (C) Adenovirus-
transduced BEAS-2B cells immunolabeled with a C-terminal SPAG16 antibody. (D) 
Analysis of SPAG16L protein expression by Western blotting in BEAS-2B cells infected 
by Ad/SPAG16S. This panel demonstrates two independent experiments. (E) Relative 
intensity of SPAG16L signal in panel D, normalized to Actin loading control for each 
sample (relative Actin signal for Ad/Control = 47.5%, for Ad/SPAG16S = 52.5%)  (* 
p<0.05 compared with pTarget or Ad/Control) 
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Figure 2-8. SPAG16S stimulates Spag16L promoter activity 
Relative luciferase activity, normalized to PGL3 control promoter plasmid co-transfected 
with pTarget control vector plasmid. Beas-2B cells were co-transfected with indicated 
promoter/PGL3 constructs (Spag16L, Spag17, and Spag6) and either pTarget or a 
SPAG16S/pTarget plasmid. Luciferase activity was measured after 48 hours to assess 
promoter function. (* p<0.05 compared with pTarget control vector co-transfection;  
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Figure 2-9. Identification of a Spag16L promoter region activated in the presence 
of SPAG16S 
Relative luciferase activity, normalized to PGL3 control promoter plasmid co-transfected 
with pTarget control vector plasmid. Beas-2B cells were co-transfected with human 
Spag16L promoter plasmids (corresponding to the indicated regions upstream of the 
transcription start site) and either pTarget control or SPAG16S/pTarget. All promoter 
constructs except the -100 bp promoter demonstrated significantly increased activity in 
the presence of  SPAG16S co-transfection. (* p<0.05 compared with pTarget co-
transfection for a given promoter) 
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Figure 2-10. Mouse and Rat Spag16S putative promoter and 5’-UTR regions 
Sequences of mouse and rat transcription start sites and putative upstream 
promoter regions. Putative transcription start sites as noted in red correspond 
with GenBank sequences (mouse – NM_025728.3; rat – BC158602). Upstream 
genomic regions are also as noted in GenBank (mouse – AY742710.2; rat – 
NC_00508: 68851813 – 68853621). Alignment analysis performed using 
MacVector v10.6. 
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Chapter 3:  Genetic Variation in SPAG16 Regions Encoding the WD40 Repeats is 
not Associated with Reduced Sperm Motility and Axonemal Defects in a 
Population of Infertile Males 
 
Abstract 
Background: SPAG16 is a critical structural component of motile cilia and flagella. In the 
eukaryotic unicellular algae Chlamydomonas, loss of gene function causes flagellar 
paralysis and prevents assembly of the “9 + 2” axoneme central pair. In mice, we have 
previously shown that loss of Spag16 gene function causes male infertility and severe 
sperm motility defects. We have also reported that a heterozygous mutation of the 
human SPAG16 gene reduces stability of the sperm axonemal central apparatus. 
Results: In the present study, we analyzed DNA samples from 60 infertile male 
volunteers of Western European (Italian) origin, to search for novel SPAG16 gene 
mutations, and to determine whether increased prevalence of SPAG16 single nucleotide 
polymorphisms (SNPs) was associated with infertility phenotypes. Semen parameters 
were evaluated by light microscopy and sperm morphology was comprehensively 
analyzed by transmission electron microscopy (TEM). For gene analysis, sequences 
were generated covering exons encoding the conserved WD40 repeat region of the 
SPAG16 protein and the flanking splice junctions. No novel mutations were found, and 
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the four SNPs in the assessed gene region were present at expected frequencies. The 
minor alleles were not associated with any assessed sperm parameter in the sample 
population. 
Conclusions:  Analysis of the SPAG16 regions encoding the conserved WD repeats 
revealed no evidence for association of mutations or genetic variation with sperm motility 
and ultrastructural sperm characteristics in a cohort of Italian infertile males. 
 
Introduction 
Infertility impacts approximately 9% of couples globally, with reports ranging from 3.5% - 
16.7% of couples (de Kretser and Baker 1999),  and it is estimated that male factor 
infertility plays a role in as many as 55% of cases (Jurewicz, Hanke et al. 2009; Chemes 
and Rawe 2010; de Kretser 2010). There are multiple causes of male infertility, including 
congenital factors and environmental exposures (Zariwala, Knowles et al. 1993; Zariwala, 
Knowles et al. 2007), as well as gene mutations which cause defects in spermatogenesis 
and sperm flagellar dysfunction.  
 
The most studied mutations associated with abnormal sperm motility and male infertility 
cause the primary ciliary dyskinesias (PCD) (Ebersold, Levine et al. 1962; Pan, Wang et 
al. 2005). Genes involved in the structure and function of the “9 + 2” axoneme, the 
principle scaffold and regulator of motile cilia and flagella, have been extensively studied 
and characterized in the biflagellate eukaryotic algae Chlamydomonas, wherein loss of 
axonemal components has been shown to cause immotility (Bastin, Pullen et al. 2000; 
Inaba 2003). Most of the mutations identified to date that cause PCD in humans encode 
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proteins that are associated with the axoneme outer doublets. However, relatively little is 
known about the contribution of mutations or genetic variation in genes encoding the 
central apparatus of the axoneme to sperm motility defects. It is known that the “9 + 2” 
axoneme is strongly conserved in overall structure and function (Sapiro, Kostetskii et al. 
2002). 
 
We previously reported that mice lacking Spag6, which encodes the mammalian 
orthologue of the Chlamydomonas axonemal central apparatus protein PF16, exhibited a 
phenotype of both male infertility associated with severe sperm motility defects and 
axonemal structural abnormalities (Smith and Lefebvre 1997; Pennarun, Bridoux et al. 
2002), demonstrating that loss of an axonemal central apparatus protein can have 
dramatic effects in mammals as well.  
 
SPAG16, the mammalian orthologue of the essential Chlamydomonas central apparatus 
protein PF20 (Zhang, Kostetskii et al. 2006), is also required for male fertility and sperm 
motility in mice (Zhang, Kostetskii et al. 2006). The Spag16 gene encodes two major 
transcripts in mice, which generate SPAG16L, a central apparatus protein, and 
SPAG16S, a protein localized to the male germ cell nucleus and cytoplasm. Male mice 
homozygous for a mutation ablating SPAG16L production have a sperm motility defect 
and are infertile (Lesich, Zhang et al. 2010). The axonemes of SPAG16L-deficient mice 
also show abnormal responses to calcium, indicating that loss of SPAG16L disrupts 
either the ability to process or the ability to respond to key molecular signaling (Zhang, 
Kostetskii et al. 2004).  When the transcripts encoding SPAG16L and SPAG16S are both 
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disrupted in a transgenic male mouse, there is haploinsufficiency and abnormal 
spermatogenesis in the chimeric state, implicating SPAG16S in fundamental processes 
of sperm formation distinct from the structural role of SPAG16L (Zhang, Zariwala et al. 
2007). Importantly, the Spag16 mutant allele affecting both isoforms was not transmitted 
to offspring by chimeric males, demonstrating that heterozygous/non-homozygous 
Spag16 mutation may cause a pronounced phenotype, and that the two murine SPAG16 
isoforms each play different but essential roles. 
 
We have also reported previously that sperm from human subjects heterozygous for a 
frameshift mutation in SPAG16 exhibited instability of important central apparatus 
components SPAG16L, SPAG17, and SPAG6 (Yatsenko, Arias et al. 2009). While both 
subjects in this report were fertile, observed biochemical instability of the sperm axoneme 
suggests that even heterozygous disruption of SPAG16 has phenotypic consequences 
that may reduce fecundity. Additionally, a preliminary study of oligozoospermic and 
oligoasthenozoospermic males has identified 29 previously unreported mutations in 
SPAG16 transcripts isolated from ejaculated sperm, further suggesting a critical role for 
SPAG16 in male fertility (Stirnimann, Petsalaki et al. 2010). 
 
In the present study, 60 males of Western European (Italian) origin volunteered for 
semen and genomic analyses following diagnosis of male factor infertility. We evaluated 
the genomic region encoding the highly conserved WD domains of SPAG16 proteins 
(exons 10-16). WD regions are semi-conserved 20 amino acid sequences giving rise to a 
β-propeller tertiary structure. These domains are the only known functional domains 
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found in SPAG16 proteins, both isoforms of which contain seven such domains. These β-
propeller structures are classically thought to mediate protein-protein interactions 
(reviewed in (Li and Roberts 2001)), playing crucial roles in macromolecular assembly 
relevant to a diverse array of cellular tasks, including cell growth and division, intracellular 
communication, apoptosis, and transcription regulation (Lau, Bachorik et al. 2009). 
Recent reports have also demonstrated that some WD domains interact directly with 
specific RNA sequences, further expanding the range of potential roles played by 
members of this class of proteins (World Health Organization 1999). 
 
To better understand potential links between SPAG16 gene variation and specific 
mechanisms of infertility, semen analysis was performed for each subject (Baccetti, 
Bernieri et al. 1995; Collodel and Moretti 2008). In addition, sperm ultrastructure was 
assessed by transmission electron microscopy (TEM) and described according to 
previously established standards (The International HapMap Consortium 2003).  
 
Based on our previous observations of Spag16 gene function in mice, and the influence 
of a heterozygous mutation affecting the WD repeat region in humans on central 
apparatus stability, we hypothesized that functional SNPs in the human SPAG16 gene 
could cause defects in sperm motility and ultrastructure manifest in both the 
heterozygous and the homozygous states. The present study analyzed genetic variation 
in a population of infertile males, and their association with parameters that are 
potentially regulated by SPAG16. 
 
67 
 
Results 
SPAG16 sequences are highly conserved 
In order to establish whether SPAG16 amino acid mutations were likely to result in 
functional changes, amino acid sequences for several species were aligned to determine 
regions of conservation within the protein. Alignments are shaded and boxed to indicate 
identical amino acids relative to the human sequence or conservative substitution (Fig. 3-
1). Quantitative assessment demonstrates greater similarity, as expected, between 
mammalian SPAG16 sequences as compared to the Chlamydomonas sequence (Table 
3-1). However, the region most conserved across all species is the C-terminal end, which 
contains the WD40 repeat domains, the only known conserved domain within these 
proteins. 
 
While SPAG16 proteins are highly conserved, phylogenetic analysis demonstrates 
especially strong relationships among mammalian forms, particularly rodents and 
primates (Fig. 3-2). Only mice have two verified SPAG16 isoforms encoded by two 
different transcripts: the flagellar form, found in all eukaryotic motile cilia and known in 
mice as SPAG16L, and a testis-specific SPAG16S, which consists of the WD repeat 
region. The only known rat SPAG16 is similar in structure to SPAG16S, and was isolated 
from testis. Furthermore, the nucleotide sequence of the 5’-UTR of rat SPAG16 mRNA 
[GenBank:NM_001134728.1] is similar to that found in mouse SPAG16S mRNA 
[GenBank:NM_025728.3]. It is reasonable to speculate that a rat SPAG16L protein exists 
containing both the conserved WD repeats on the C-terminal end and an approximately 
equally sized N-terminus, consistent with the protein’s structure in all other species. 
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Analyzed SPAG16 SNP allele frequencies are not altered in the sample population 
For one SNP analyzed by Taqman Genotyping Assay, rs10167688, no individuals with 
the minor allele were detected. This result was further corroborated by exon region-
specific sequencing. Heterozygosity for this SNP has been reported only in West African 
Yoruban populations (The International HapMap Consortium 2003), so its absence in our 
population was not unexpected.  The probe set used to analyze this SNP was confirmed 
to be effective using a test set of West African female DNA samples obtained in an 
unrelated study (data not shown). 
  
Two other SNPs were analyzed by TaqMan assay and confirmed by genomic 
sequencing, which also demonstrated two additional SNPs present within splice 
junctions. For all four of these SNPs, minor allele frequencies in our patient population 
did not differ significantly (rs2042791: p = 0.86; rs2042792: p = 0.49; rs12623569: p = 
0.87; rs16851495: p = 0.20) from those reported in previous genomic studies of a 
reference population (Table 3-2) (Ng and Henikoff 2003). Each allele was found to be in 
Hardy-Weinberg equilibrium. No other alternate alleles corresponding to SNPs identified 
in previous genomic sequencing studies were found in the sample population. However, 
the minor allele frequencies for all of putative SNPs not found in the present study 
population are quite low or unconfirmed in the reference population (Table 3-3). 
 
Of the four SNPs analyzed, two SNPs were found to be in linkage disequilibrium, 
rs2042791 and rs2042792 (Table 3-4).  
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Analyzed SPAG16 SNPs are not associated with alterations of axonemal or 
periaxonemal ultrastructure, fertility index, and sperm parameters 
In the infertile male population studied, semen analysis revealed severe defects in sperm 
concentration, motility, and ultrastructure (full data in Table 3-5). No single parameter 
was uniformly perturbed amongst all patients carrying a particular SNP minor allele. 
Additionally, no mutation was found for which all homo- or heterozygous carriers 
displayed a similar phenotype beyond deficiencies common to the sample (infertile) 
population in general. There were nominally significant associations found between 
specific SNPs and sperm ultrastructural characteristics, but these were not significant 
after Bonferroni correction for multiple testing of 18 phenotypes with 7 genetic variations 
(4 SNPs and 3 haplotypes), which resulted in a Bonferroni corrected p ≤ 0.000397 to 
indicate significance at the 5% level. Minor allele carriage at rs16851495 correlated 
negatively, but not significantly after Bonferroni correction for multiple testing, with normal 
axoneme structures (β = -0.16, nominal p = 0.039) and with normal accessory fiber 
structures (β = -0.12, nominal p = 0.041;). Minor allele carriage at rs12623569 showed a 
small, nominally significant, positive correlation with normal fibrous sheath structures (β = 
0.09, nominal p = 0.14) (Table 3-6). 
 
For two SNPs [dbSNP: rs2042791; dbSNP rs2042792] in LD, haplotype was not 
associated with studied sperm parameters or ultrastructural variation (Table 3-7). 
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Amino acid-altering SPAG16 SNPs are predicted to be functionally tolerated  
Two of the identified SNPs cause point mutations in SPAG16 proteins. These amino acid 
substitutions were assessed for predicted effects on protein structure and function. Both 
amino acid substitutions were predicted to be tolerated using SIFT (Schwede, Kopp et al. 
2003), which analyzes amino acid properties and conserved identities.  
 
The crystallographic structures of other WD repeat proteins have been determined and 
these structures can be used to model the structure of the SPAG16 WD repeat region. 
Using SWISS-MODEL (Sherry, Ward et al. 2001), SPAG16L was evaluated for homology 
with proteins of known structure, and the amino acid sequence was aligned with that of 
WDR5Delta23, a member of the WD repeat protein family.  The locations of the amino 
acid residues affected by the SNPs evaluated are labeled in the 3-D structure model 
shown in Figure 3-3.  K425 is predicted to be located on the periphery of the molecule, 
which is not a known binding site of the structural homologue WDR5Delta23. Q361 
extends into the predicted binding pocket. 
 
Discussion 
In the SPAG16 regions analyzed, both major and minor alleles were present in the study 
group for four known polymorphisms, and no previously unreported mutations were 
detected.  At rs2042791 (The International HapMap Consortium 2003), the minor allele 
replacement of an adenosine by a cytosine residue causes the replacement of a 
glutamine at position 361 [GenBank: NP_078808.3] with a histidine. Previous genotyping 
studies have reported a minor allele frequency of 0.39 (Ng and Henikoff 2003) in 
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individuals of Caucasian ancestry for this SNP. Fisher’s exact test demonstrated no 
significant difference between the measured minor allele frequency of 0.408 in our 
sample population and that established in control populations (p > 0.05). While the 
present study lacks sufficient power to detect small effects of these alleles on variation in 
observed parameters of sperm characterization, among patients carrying this SNP no 
single factor was uniformly deficient within the distribution of sub-normal semen analysis 
of the study participants. Full genotype and semen analysis results are included for 
reference (Supplemental Table 2). 
 
The lack of association between this SNP and sperm dysfunction is not surprising, given 
that the glutamine replacement by histidine is predicted to be tolerated in the protein 
structure (The International HapMap Consortium 2003). Further, the amino acid is not 
conserved in mammals – Mus musculus [GenBank:AAI20669.1, NP_080004.1, 
NP_083436.2] and Rattus norvegicus [GenBank:NP_001128200.1, AAI58603.1] 
reference sequences for the orthologous proteins in fact report a histidine at this position, 
consistent with the human minor allele. The same amino acid replacement is predicted in 
Pan troglodytes [GenBank:XP_001148592.1, XP_526016.2, XP_001148393.1]. These 
data are consistent with the hypothesis that structural rather than sequence homology is 
essential to maintenance of axoneme function. 
 
The rs2042792 minor allele was not found at a significantly different frequency than in the 
reference population (p > 0.05), and did not correlate with assessed sperm phenotypes. 
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Rs2042791 exists in LD with rs2042792 in our population, but no phenotypic 
consequences were associated with any of the observed haplotypes.  
 
Minor allele replacement of an adenosine with a cytosine in rs12623569 causes an 
amino acid replacement at position 425 [GenBank:NP_078808.3], with a threonine taking 
the place of a lysine. Previous genotyping studies have shown a minor allele frequency 
for this SNP in individuals of Caucasian ancestry of 0.30 (Nagarkatti-Gude, Jaimez et al. 
2011). The present sample population exhibited a minor allele frequency of 0.333, which 
was not significantly different than that in control populations (p > 0.05). While the lysine 
at position 425 encoded by the major allele is present in other mammals (Mus musculus 
– GenBank:NP_080004.1, NP_083436.2; Rattus norvegicus – 
GenBank:NP_001128200.1, AAI58603.1), replacement by threonine is predicted to be 
tolerated by the protein structure. Interestingly, minor allele carriage was found to be 
nominally associated with a higher percentage of normal accessory fibers of the 
axoneme.  Although the statistical significance of this association was lost upon 
correction for multiple testing, further studies on a larger study population may be 
warranted to identify contributions of the SNP to sperm flagellar structure. 
 
At rs16851495, minor allele replacement of guanine with an adenine residue does not 
affect protein translation directly, as the position lies outside the translated exon region. 
However, minor allele carriage was nominally associated with the reduced presence of 
normal axoneme structure in the study population.  The statistical significance of this 
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association did not withstand correction for multiple testing.  However, the limited power 
of our study may have contributed to the absence of a robust association.  
 
For all SNPs discussed, both heterozygous and homozygous individuals were present in 
the sample population, and statistical analysis demonstrated no difference in genotype 
frequency between the sample and control populations (p > 0.05). While the study did not 
have sufficient power to analyze possible contributions to complex traits, the results 
negate the hypothesis that amino acid modification at the tested positions may result in a 
loss of protein function that would mimic the severe phenotypes observed in transgenic 
mouse studies. 
 
Our results suggest that non-synonymous amino acid substitutions at residues 361 and 
425 in the SPAG16 protein are not sufficient to explain a reduction of sperm motility and 
fertility index, the presence of axonemal/periaxonemal alterations, or an increased 
percentage of sperm pathologies in the assessed patient population. Based on the strong 
homology between members of the WD protein family, it is tempting to suspect that these 
resides may be non-essential in other WD repeat proteins as well.  
 
The profound defects observed in studies of Spag16 gene effects in other species 
suggest that a functional mutation would significantly perturb sperm function, and would 
be observed even in a small sample population. Our observations do not, however, 
preclude the possibility that alternative variations in the SPAG16 gene cause an increase 
in sperm ultrastructural alterations, and a reduction in sperm motility. Indeed, our 
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previous studies suggest that more significant SPAG16 mutations, such as a frameshift, 
can reduce sperm central apparatus stability. Further studies of SPAG16 gene variation 
are warranted to offer a comprehensive understanding of the gene’s contributions to 
male fertility. The sensitivity of the present study to detect variation with the sample is 
limited by the lack of similarly extensive sperm analysis data, in particular TEM 
ultrastructural analysis, from a control population. Future development of this area of 
research should include control samples from men with known fertility and/or sperm 
count, motility, and structure in the normal range. 
 
Future studies in mammals are necessary as well to explore the nature of Spag16 gene 
evolution, and the possibility that male germ cell-specific isoforms exist in multiple 
species. The only identified rat SPAG16 protein is similar to SPAG16S in size, and is 
derived from mRNA similar to murine SPAG16S, with a 5’UTR from the region upstream 
of the first exon suggestive of independent transcription, rather than splice variation. A 
putative SPAG16S promoter and 5’UTR have been identified in humans as well 
[GenBank: EF591776.1], raising the possibility that SPAG16S maybe be common to 
mammalian male germ cells. We have recently shown that murine SPAG16S is enriched 
within nuclear speckles of male germ cells (Sherry, Ward et al. 2001; The International 
HapMap Consortium 2003). This unique localization, combined with phenotypic results 
from various Spag16 transgenic mice, strongly suggests a unique processing role for the 
SPAG16S protein, and thus a distinct role for the Spag16 gene apart from its structural 
role in the axoneme.  
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Conclusions 
In a sample population of 60 infertile males of Western European origin, mutations in 
SPAG16 were not significantly associated with a single phenotype of sperm alteration. 
The findings suggest that mutations and or genetic variation in the SPAG16  regions 
encoding the protein’s WD repeats are not likely to be major causes of sperm motility and 
sperm flagellar defects. 
 
Materials and Methods 
DNA sample acquisition 
DNA used in the present study was isolated from peripheral blood lymphocytes submitted 
by 60 male volunteers of Western European (Italian) ancestry diagnosed clinically as 
sub- or in- fertile. Inclusion criteria for patients were: sperm progressive motility  10%, 
normal lymphocyte karyotype, normal hormone levels, absence of anatomical 
pathologies, genitourinary infections. Patients with known ultrastructural sperm defects of 
possible genetic origin (dysplasia of the fibrous sheath, cilia immotile syndrome, round 
headed sperm, etc.) were also excluded.  
 
Ethics 
Research was carried out in full compliance with the Helsinki Declaration of ethical 
principles for medical research involving human subjects. All patients signed a 
declaration of informed consent to participate in the research. The work was approved of 
and performed in full accordance with policies governing human subject research at the 
by the Ethics Committee for the University of Siena (CEL-AOUS) for specimens collected 
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by non-invasive methods for clinical analysis, and the Virginia Commonwealth University 
Institutional Review Board.  
 
Genotyping 
Allelic genotyping was performed using Applied Biosystems TaqMan SNP Genotyping 
Assays according to manufacturer’s instructions. Specific allelic discrimination probes 
and primer sets were ordered for the following 3 SNPs:  dbSNP: rs2042791, rs12623569, 
rs10167688. Results were compared to allele frequency detected in NCBI and HapMap 
studies (Purcell, Neale et al. 2007). 
 
Genotype was confirmed by direct sequencing. Briefly, exon plus flanking regions were 
amplified by PCR and sequenced using tested primers. Primer suitability for sequencing 
was tested by comparing results to sample PCR products digested and amplified in a 
Topo TA Vector (Invitrogen). 
PCR and Sequencing Primers 
Ex10 – Forward: 5' - TTCATGTAAATTCTGGGCAAA - 3'; Reverse: 5' - 
GCAAACCATTTCAACCATGA - 3' 
Ex11 – Forward: 5' - TGGGGCCAGTACTCTCAAAA - 3'; Reverse: 5' - 
TTCAGTGCAGGGTGTGTTGT - 3' 
Ex12 – Forward: 5' - GCAATTCAAGTTAGCAATTGTG - 3'; Reverse: 5' - 
CCTGGGGTAGCATCAAGG - 3' 
Ex13 – Forward: 5' - TTATTTCATGCCTCAGTTCCTT - 3'; Reverse: 5' - 
GCCCTTGCACAATCACTTTT - 3' 
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Ex14 – Forward: 5' - GGGAGGAGGGGCTAAAAATTA - 3'; Reverse: 5' - 
CCTAAAGTTGTTCTTCTCACCTCA - 3' 
Ex15 – Forward: 5' - AGAGGAATGTAATCTTATGGCTGT - 3'; Reverse: 5' - 
TTCATATGACATGCTATACGTAATGA - 3' 
Ex16 – Forward: 5' - CTGACCCCTAACACAGAATGA - 3'; Reverse: 5' - 
CCAGGTTTTCCTGCAGTTT - 3' 
 
Statistical analysis 
Fisher’s exact tests implemented in the open-source R software package were used to 
test for differences between allele frequencies observed in the sample population and 
those reported in HapMap for a population of Western European origin (Purcell, Neale et 
al. 2007). Hardy-Weinberg equilibrium tests and inter-SNP linkage disequilibrium 
calculations were performed using PLINK (World Health Organization 1999). Haplotypes 
were assigned to subject based on the most likely phase reconstructed haplotype 
generated by the expectation-maximization algorithm implemented in PLINK. Haplotypes 
were then imported to R and an additive term for the haplotype of interested was coded 
as 0, 1, or 2 based on copy number present. Single SNP and haplotype associations with 
all phenotypes were carried out using multiple logistic regression in R. Phenotypes 
measured as percentages were transformed with arcsine of the square root of the 
percentage to stabilize the differences in variance between samples. The Fertility Index is 
a standard measure ranging from 0 to 100+. All values greater than 100 were coded as 
100. To achieve a more normal distribution and minimize residual errors, sperm/mL was 
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analyzed using a log transformation. A Bonferroni p value was calculated to correct for 
multiple testing error. 
 
Sperm analysis 
Semen samples of patients were collected by masturbation after 4 days of sexual 
abstinence and examined after liquefaction for 30 min at 37°C. Volume, pH, 
concentration (sperm x 106/mL) and total motility (a, rapid + b, slow, + in situ) were 
evaluated according to World Health Organization guidelines (Baccetti, Bernieri et al. 
1995; Collodel and Moretti 2008). For electron microscopy, sperm samples were 
prepared as previously described (Baccetti, Bernieri et al. 1995). 
 
In each sample the percentage of normal axonemal pattern, of coiled axonemes, of well-
assembled fibrous sheaths and accessory fibers were estimated by TEM. Moreover, all 
TEM data were elaborated using the statistical mathematical formula by Baccetti et al. 
(Collodel and Moretti 2008), based on the Bayesian method, which calculates the 
number of spermatozoa probably free of structural defects (fertility index, FI) and the 
percentages of three main phenotypic sperm pathologies: immaturity, necrosis and 
apoptosis (Schwede, Kopp et al. 2003).  
 
Molecular structure prediction 
Using SWISS-MODEL (Ng and Henikoff 2003), mouse SPAG16L was evaluated for 
homology with proteins of known structure, and the results mapped on the 3-D structure 
of the most closely related homologue. 
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The molecular analysis tool SIFT (Thompson, Higgins et al. 1994) was used to predict 
whether the analyzed amino acid substitutions would be tolerated, based on sequence 
homology and amino acid physical properties. 
 
Amino Acid Alignment 
Alignment analysis, including scoring of conservative versus semi-conservative or radical 
amino acid substitutions, was performed using recommended default settings in 
MacVector 11.6 (MacVector. Inc.; Cary, NC) for the following isoforms: 
Homo sapiens – GenBank:NP_078808.3  
Mus musculus – GenBank:NP_083436.2 
Bos taurus - GenBank:DAA32462.1 
Gallus gallus - GenBank:XP_421865.2 (predicted) 
Pan troglodytes - GenBank: XP_001148592.1 (predicted)  
Chlamydomonas reinhardtii  - GenBank:AAB41727.1  
Micromonas sp. RCC299 - GenBank:ACO61299 
 
Maximum Likelihood Tree 
Amino acids sequences were aligned by ClustalW (CLUSTALW) using default settings, 
hosted by GenomeNet at the Kyoto University Bioinformatics Center (Felsenstein 2005). 
Aligned sequences were analyzed for maximum likelihood tree and formatted for figure 
output using programs in the Phylip 3.69 software package (Li and Roberts 2001). 
Isoforms used were as follows: 
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C. reinhardtii – GenBank:AAB41727.1 
M. pusilla CCMP1545 – GenBank:EEH57835.1 
E. siliculosis – GenBank:CBN79843.1 
P. patens – GenBank:EDQ58898.1 
T. brucei – GenBank:AAC83819.1 
T. gondii ME49 – GenBank:EEA99732.1 
(Rooster) G. gallus – GenBank:XP_421865.3 (Predicted) 
(Opossum) M. domestica - GenBank:XP_003341903.1 (Predicted) 
(Macaque f.) M. fascicularis – GenBank:BAE01109.1 
(Rhesus macaque) M. mulatta – GenBank:XP_001082826.2 (Predicted) 
(Gibbon) N. leucogenys - GenBank:XP_003254083.1 (Predicted) 
(Chimpanzee) P. troglodytes - GenBank:XP_001148592.1 (Predicted) 
(Human) H. sapiens N-terminal variant – GenBank:NP_001020607.1 
(Human) H. sapiens SPAG16L – GenBank:NP_078808.3 
(Bull) B. taurus - GenBank:DAA32462.1 
(Rat) R. norvegicus (discovered in testis; SPAG16S homologue) – GenBank:AAI58603.1 
(Mouse) M. musculus SPAG16S – GenBank:NP_080004.1 
(Mouse) M. musculus SPAG16L – GenBank:NP_083436.2  
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Figure 3-1. Alignment of SPAG16 amino acid sequences 
Aligned amino acid sequences are given for full-length proteins in human, mouse, 
bull, rooster, chimpanzee, Chlamydomonas, and Micromonas. 
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Table 3- 1. SPAG16 amino acid sequence conservation analysis 
Quantitative assessment of identity scores (starting from left column) and similarity 
scores (starting from top row), as calculated by MacVector alignment using default 
settings. 
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Figure 3-2. Sequence analysis of SPAG16 proteins 
Maximum likelihood tree of SPAG16 and SPAG16-orthologous proteins (e.g. PF20). 
The accession numbers for each entry are listed in the methods section. 
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Table 3- 2. SPAG16 SNP distributions in sample population 
Major and minor allele representation in the sample population. SNPs rs2042792 
and rs16851495 are located in non-coding exon splice regions, while SNPs 
rs2042791 and rs12623569 are in coding regions of SPAG16 mRNA, and alter 
amino acid translation. The nucleic acid and amino acid positions indicated refer, 
respectively, to mRNA GenBank:NM_024532.3 and to protein 
GenBank:NP_078808.3. Expected frequencies refer to the HapMap CEU 
(European) study (The International HapMap Consortium 2003). 
 
The sequenced region area also covered the following SNPs, for which no minor 
alleles were found in the sample population: rs10167688, rs115473269, 
rs61752199, rs2248214, rs28606463, rs114135655, rs113852644, rs117619722, 
rs6746741, rs71855401, rs12988372, rs12988374, rs80016542. Location and 
expected frequencies for SNPs not present in the sample population are given in 
Table 3-3. 
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Table 3- 3. Minor allele frequencies of all SNPs in the tested SPAG16 region 
Expected minor allele frequencies refer to HapMap CEU European population (Baccetti, 
Bernieri et al. 1995) where available. Unknown = no data available for suitable reference 
population; * = Pilot 1 HapMap CEU panel, 60 individuals 
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Table 3- 4. Analysis of Linkage Disequilibrium in Exon 11 SNPs 
Linkage equilibrium analysis of two SNPs found in the sample 
population and present in the genomic proximity: in order, rs2042791 
and rs2042792. ‘2’ indicates minor allele, ‘1’ indicates major allele. 
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Table 3- 5. Tests for association between all SNPs in sample population and sperm phenotype 
Association tests for each SNP found in the sample population and studied indicators of sperm structure and function. * = 
data assessed using arcsine of the square root of the phenotype; ^ = data assessed using log transformation of the 
phenotype; c = Bonferroni correction results in p > 0.1 
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Table 3- 6. Tests for association between haplotypes and sperm phenotype 
Association tests for rs2042791-rs2042792 haplotypes and studied indicators of sperm structure and function. 2’ indicates 
minor allele, ‘1’ indicates major allele. Transformations as in Supplemental Table 2, * = data assessed using arcsine 
transformation; ^ = data assessed using log transformation. 
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ID
rs204
2791 
rs204
2792 
rs126
23569 
rs168
51495 
Ax 
nor 
(9+2) 
Ax 
coiled
Acc 
fibers 
nor
Fibrous 
Sheath 
nor
Spm/
mL 
10
6
Vol 
/ 
mL
Motility 
a+b
in 
situ
FI Imm Apopt Necr Path
Hormo
nes
Semen 
Infecti
ons
101 1 1 0 0 11/24 7/28 12/20 1/18 0.975 4 3+5 5 60 52.86 15.7 67.9 ExVaLf
Strp. 
Anginosu
s
102 2 2 0 0 0/23 19/23 1/23 0/21 74 2.5 0+1 1 0 94.61 21.9 98.7 ExVaLf
103 2 2 0 1 0/18 16/30 3/22 3/27 0.48 3 0 0 0 65.75 12.5 98.4
E.Faecali
s
104 1 1 1 0 6/31 9/26 6/22 6/24 4.88 5.5 3+5 10 193 86.58 4.1 61.3
105 1 1 0 0 8/13 2/13 4/8 2/11 0.8 3.5 0+10 2 479 70.68 14.6 51.7 ExVaLf
106 1 1 0 1 4/27 13/32 5/23 3/22 1,925 1.9 0+10 0 0 63.77 43 93 VaLf  E.Coli
107 1 1 1 0 0/16 9/27 4/12 2/14 47.25 1 0+1 3 0 70.63 6.8 88.7 ExVaLf
Strp. 
Agalactia
e
108 1 1 1 1 3/13 9/13 3/9 5/10 4 8 2+5 4 609 87.6 18 72.6 VaBil  E. Coli
109 0 0 2 0 7/20 10/27 3/11 11/16 19.5 3.8 0+1 10 11,796 78 6.8 79.3
110 1 1 1 1 6/25 10/26 3/19 3/22 92.5 3.6 0+6 12 34,366 58.94 0.9 54.3
111 1 1 0 0 10/24 5/25 3/15 13/23 4 5 0+3 13 1,073 63.03 11.2 53.7 VaLfidRg
E.Faecali
s/Faeciu
m
112 0 0 1 1 2/21 8/25 2/16 5/20 2.2 4.7 4+4 2 98 72.37 9.2 47.5
Table 3- 7. Genotype and phenotype analysis of each study participant 
Semen parameters and TEM sperm analysis results for each patient. For SNPs, 0-2 indicate number of minor alleles at 
the given location, hence 0 = homozygous major allele, 1 = heterozygous, 2 = homozygous minor allele. Ax norm = 
Normal axoneme structure 9+2 by TEM examination; Ax coiled = Coiled axoneme by TEM examination; Accfibers norm = 
Normal accessory fibers structure by TEM examination; Fibrous sheath norm = normal fibrous sheath structure by TEM 
examination; FI = Fertility Index; Imm = % Immaturity (normal < 55%); Apopt = % Apoptosis (normal < 5%); Necr = % 
Necrosis (normal <21%). FI and sperm pathologies (immaturity, apoptosis, necrosis) were assessed by TEM . VaLf = Left 
varicocele; CripRg = Right Cryptorchidism; ExVaLf = Operated Left Varicocele; VaRg = Right Varicocele; VaBil = Bilateral 
Varicocele 
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113 2 2 0 0 6/22 8/23 8/23 7/22 21.2 2 3+1 9 3,920 68.55 13.67 20.05 VaLf
UUrealyt
icum. 
G.Vagin
alis
114 1 1 1 0 13/27 8/27 9/20 7/23 36.5 2 7+2 9 23,838 74.53 21.88 16.36
115 1 1 1 0 4/25 19/30 1/21 6/26 0.325 2.5 0 0 0 72.85 11.2 87.5 ExVaLf LH ?
116 0 0 0 0 9/22 7/23 4/17 6/21 99 2.5 3+1 5 1,099 71.57 6.8 58.8
 E. 
Faecalis
117 0 0 1 1 8/24 10/24 7/18 7/22 1.3 2 3 1 243 74.5 6.72 41.23
118 1 1 1 0 5/20 4/22 2/16 6/20 3.6 2 6+1 0 1 59.03 43.07 36.42 VaBil
119 1 0 2 1 5/25 9/34 4/26 14/30 28 3 2+0 5 2,593 55.52 4.7 83.2 VaLf
Strp. 
Agalactia
e.Bovis I
120 1 0 1 0 7/26 9/26 5/25 9/25 5,375 5 0+9 0 641 52.36 37.4 85.1 ExVaLf
121 1 1 0 0 7/25 5/25 2/23 5/24 15 1.5 0+3 3 0 48.03 37.3 77.5 VaLf
122 1 1 1 1 9/26 8/28 7/22 10/23 13.5 2.5 7+3 8 14429 58.24 9.2 67.38 VaLf
123 1 0 0 0 3/18 9/16 4/18 5/16 0.9 3 2 0 0 75.5 12.4 88.67 Exvabil
124 0 0 0 0 2/21 12/25 5/20 0/19 8.75 5 3+6 0 2 68.88 19.23 53.31
125 1 1 1 1 5/23 6/23 3/21 3/22 h 2.5 1+2 1 7 77.3 24.9 62.14
126 1 1 0 0 0/16 3/19 8/14 2/15 4.5 1 1+1 0 1 58.17 0.69 62.23
127 1 1 1 1 14/30 9/32 4/26 13/26 19.8 4 5+5 2 152,796 67.77 9.4 25.9
128 1 1 1 0 4/30 19/35 5/30 4/29 8.75 1.5 2+7 4 25 85.45 12.8 43
129 1 0 0 0 3/27 13/28 1/22 5/27 6.5 2 4+4 6 8 78.07 18.3 37.5 VaLf
 
E.Faecali
s
130 0 0 0 0 14/30 10/31 4/26 8/25 8.7 2 3+2 1 100 91.54 17.49 36.51 VaLf
131 0 0 1 0 14/22 7/27 5/16 10/21 3.75 2.5 7+3 11 50,746 58.82 28.48 12.94
132 1 1 1 0 15/21 14/28 8/18 4/16 13.5 0.5 8+2 7 2,293 85.62 8 45.17
133 0 0 0 0 8/19 8/18 4/17 2/16 3.75 5 3+4 1 3 76.64 23.21 68.24
134 1 1 1 1 9/18 9/18 5/14 4/14 4.4 5 6+2 4 48 73.95 13.68 68.66 VaLf
135 2 2 0 0 12/22 10/29 6/20 5/18 173 1.2 2+3 2 66,814 66.65 0.79 42.51
136 1 1 0 0 2/32 25/32 1/24 2/26 14.87 3 2+0 0 89 86.06 7.9 85.44 VaLf
137 2 2 0 0 1/20 9/20 3/18 4/19 287 2 0+1 1 30367 44.2 4.2 90.22
138 0 0 1 1 4/24 4/24 16/19 5/16 125 5 5+1 1 1E+06 50.74 8.06 51.41
U 
Urealytic
um
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139 2 2 0 0 13/23 8/25 6/21 7/19 7.6 5 5+3 1 17,635 69.91 7.59 22.62 VaLf
140 0 0 2 0 11/22 13/26 10/20 10/21 7.25 2.5 4+3 2 10,265 84.23 9.3 32.4
141 0 0 0 0 6/21 16/23 5/23 1/28 1.75 2.5 1+2 0 2 85.07 16.2 66.2 ExVaLf LH ↓
142 0 0 1 0 3/26 8/28 7/25 4/23 50.25 1.2 2+0 7 5,733 40.98 2.7 90
 
E.Faecali
s
143 1 1 0 0 3/20 10/20 2/15 7/20 0.32 5 4+4 2 41 77.8 3.6 61.7
U 
Urealytic
um
144 1 1 1 0 9/25 15/27 10/25 8/21 1.93 3 4+1 5 431 83.47 26.2 60 VaLf FSH ↑
145 0 0 1 1 6/29 10/32 6/26 4/28 1 3 4+2 2 12 80.47 5.5 91.4
 
E.Faecali
s
146 0 0 1 0 9/25 12/26 6/23 9/24 3.4 6 2+2 4 47 77.8 17.8 72.6 VaLf FSH ↑
147 1 1 0 0 5/13 2/13 2/12 6/13 0.3 8.5 0 0 1 64.43 20 38.6 VaBil
148 0 0 1 1 2/24 12/26 0/23 3/25 9.5 1.8 1+3 5 0 78.11 24.7 67.8 VaLf
LS 
E.Faecali
s
149 1 1 0 0 4/16 5/17 4/12 5/13 0.95 1.4 0+8 11 0 49.91 14.5 69 FSH ↑
150 1 0 0 0 8/22 5/22 4/16 6/20 12.88 5.1 6+4 4 4,567 55.97 16.3 79 VaLf
Strp. 
Agalactia
e
151 2 0 0 0 2/20 12/31 7/23 4/21 177.5 1.9 1+0 0 995 61.7 6.2 92.2
 
VaLfCrip
Rg
152 0 0 2 0 4/22 9/23 4/20 5/20 8.37 4.8 3+4 9 334 78.5 8.9 41.5
153 1 1 1 0 10/26 8/26 11/20 9/23 6.3 8 3+4 7 15,664 77.7 0.8 55.1 ExVaLf
154 1 1 0 0 1/24 16/25 1/23 2/23 0.325 1.5 0 0 0 73.17 13.5 96.5
 
E.Faecali
s
155 0 0 1 1 4/21 11/31 4/27 5/23 57.75 1.2 0+1 1 57 58.44 11.8 92 VaLf 
156 0 0 0 1 0/34 16/35 3/33 3/31 69 6 1+2 5 0 57.3 25.8 96.2
157 2 1 0 0 2/28 16/28 3/27 2/26 4.5 2 1+7 3 28 81.14 10.1 61.5 ExVaLf
158 0 0 2 1 0/24 8/27 5/24 2/22 10.25 1.5 0 0 0 78.5 6.8 58 VaRg
159 1 0 2 0 4/35 25/34 4/31 5/32 9.2 1.2 0+1 2 142 86.95 12.8 73.2 FSH ↑
160 1 1 0 0 6/23 12/24 3/22 2/23 6.05 9 0+2 4 1 71.34 10.9 84.5 VaLf
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Figure 3-3. Predicted approximate 3-D structure of SPAG16 
Predicted 3-D structure of human SPAG16L as determined by overlay on the known 
structure of WDR5Delta23, the closest related protein with a known crystal structure. 
Location of SNP-affected amino acids is indicated by shaded sections. 
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Chapter 4:  Perspectives 
 
Throughout the course of this dissertation, I have presented data that describe the roles 
of Spag16, a bifunctional gene playing a highly conserved role in eukaryotic motile cilia 
as well as an important role in mammalian male germ cell development. The involvement 
of Spag16 in spermatogenesis has been suggested by previous work, predominantly 
published by our lab, and is a particular focus of the work presented here. 
 
In Chapter 1, I presented background information for the dissertation, beginning with the 
twin clinical goals that have prompted these studies: understanding male infertility, and 
developing male contraceptives. Previous studies by our lab have strongly suggested a 
novel role for the mammalian Spag16 gene aside from its conserved structural role, 
leading to the central hypothesis of this work that Spag16 has evolved an additional 
function unique to mammalian male germ cells. This prior work from our lab has shown 
that mice have two distinct isoforms of SPAG16: a longer SPAG16L that fulfills the 
conserved structural role in all eukaryotic motile cilia, and a shorter SPAG16S, found only 
in male germ cells and present in the nucleus as well as the cytoplasm. While transgenic 
mice lacking SPAG16L are infertile and show defects in sperm motility, mice with both 
SPAG16S and SPAG16L disrupted fail to transmit the mutant allele, and exhibit a 
phenotype of spermatogenesis arrest at the round spermatid stage, leading us to 
hypothesize that nuclear SPAG16S plays an important role in sperm maturation. 
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In Chapter 2, I presented new information on the localization of murine SPAG16S, 
demonstrating that the protein concentrates in sub-nuclear structures known as nuclear 
speckles. The appearance of these SPAG16S-enriched nuclear speckles is concurrent 
with haploid sperm maturation at the round spermatid stage, the point of 
spermatogenesis at which sperm development was disrupted in a highly chimeric 
transgenic mouse with SPAG16S (as well as SPAG16L) disrupted. I also demonstrated 
that SPAG16S is capable of eliciting SPAG16L expression and of binding to the Spag16L 
promoter. While these data do not explain the phenotype seen with disruption of 
SPAG16S, they provide the first evidence of a specific SPAG16S function, consistent 
with the gene regulatory role suggested by SPAG16S localization in nuclear speckles. 
 
In Chapter 3, I examined a patient population of 60 infertile males with low sperm motility 
to see if SPAG16 gene mutations might be a contributory factor to their infertility. I 
designed primers to fully sequence exonic regions of SPAG16 corresponding to the 
shared SPAG16L and SPAG16S functional domains. No novel mutations were found, 
and previously reported SNPs were found at a frequency not significantly different from 
that found in a control population, Europeans enrolled in the International HapMap study. 
Extensive EM and semen analyses were performed by our collaborators, and we tested 
these sperm parameters for association with SNPs and haplotypes in our patient 
population. After correction for multiple testing, no significant associations were found. 
These data suggest that identified SPAG16 polymorphisms are not functionally 
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detrimental to either SPAG16L or SPAG16S, as we have seen that loss of these proteins 
carries significant phenotypic consequences in mice. 
 
Related Projects 
This section will discuss related work to evaluate the full implications of the presented 
data, suggest insights into functional mechanisms, and outline directions of future study. 
Given that the only identified functional domains of both SPAG16S and SPAG16L are 
WD repeats, which are known to mediate protein-protein interactions, it is highly likely 
that both proteins function via interaction partners. Three yeast two-hybrid screens have 
been performed (two within the context of this dissertation, one previously) using the 
mouse SPAG16S/C-terminal SPAG16L sequence as bait against libraries of normalized 
mouse and mouse testis cDNA (Clontech).  
 
The results of the these interaction studies have varied, perhaps suggesting that 
SPAG16 proteins are promiscuous but unenthusiastic interactors outside the presence of 
defined macromolecular structure components, such as the conditions found surrounding 
SPAG16L in the axoneme central apparatus. Despite ongoing efforts, thus far it has not 
been possible to reliably predict WD interactors based on analysis of any putative 
epitope-like specific sequences within WD repeats (Zhang, Kostetskii et al. 2004). The 
putative interactors presented below suggest possible SPAG16 functions by association. 
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Meig1 
Our lab published the first studies suggesting an interaction between SPAG16 and 
MEIG1 (Don, Winer et al. 1994; Ever, Steiner et al. 1999), a 15-kDa protein expressed 
abundantly in murine testes during and immediately after meiosis (Zhang, Kostetskii et al. 
2004). Based on yeast two-hybrid screens and supported by co-immunoprecipitation, an 
important interaction was hypothesized between the WD region of SPAG16 and Meig1 
(Steiner, Ever et al. 1999). 
 
Initial results in the literature theorized that MEIG1 played an important role in the early 
stage of meiosis, when it was observed in the nucleus interacting with spermatocyte 
chromosomes (Zhang, Shen et al. 2009). The nuclear localization of MEIG1 suggested 
an interaction with SPAG16S, rather than SPAG16L, yet the spermatogenesis arrest in 
the chimeric SPAG16 mouse at the round spermatid stage led to a hypothesis that the 
crucial role for SPAG16S occurred post-meiotically. 
 
In order to better understand the germ cell-specific roles of the MEIG1 protein, and shed 
light on the importance of SPAG16S interaction, a conditional Meig1 knockout mouse 
was generated (Clermont, Oko et al. 1990; Zhang, Shen et al. 
2009)(http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746124/). Homozygous Meig1-null 
mice were found to be viable, but completely sterile, with very few, morphologically 
abnormal sperm. There were no other observed defects that would suggest ciliary 
immotility. Importantly, spermatogenesis in Meig1-null males progressed normally 
through meiosis, refuting the hypothesis that MEIG1 plays a critical role at this juncture. 
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However, the final stages in sperm development, those of elongation and condensation, 
failed to progress. A failure of spermiogenesis after the round spermatid stage strongly 
resembles the phenotype of the Spag16 chimeric mouse ascribed to lack of SPAG16S, 
and provides interesting anecdotal support for the hypothesis that MEIG1 and SPAG16S 
interact at the round spermatid stage to regulate the final stages of sperm development. 
 
Spermiogenesis disruption in Meig1-null males was linked to a specific ultrastructural 
defect, failure of manchette formation. The manchette is a transient microtubular 
structure that assembles during spermatid elongation, and is believed to play a role in 
transport of proteins within the developing sperm tail (Salzberg, Eldar et al. 2010). In 
sperm from Meig1-null males, components of this structure, such as actin and tubulin, 
were observed to be present in the cytoplasm, yet disorganized.  
 
A similar, independent study noted the same phenotype of sterility and lack of sperm 
development in the elongation and condensation stage. Scanning EM revealed the 
presence of gross sperm head malformations and misconnections to the tail, yet did not 
address sub-cellular structures such as the misformed manchette components we 
reported (Zhang, Kostetskii et al. 2004). 
 
Both of the above-referenced studies were conducted in animals with a global 
inactivation of Meig1. In order to establish the timing of MEIG1 activity and to confirm the 
germ cell specificity of the phenotype, the conditional knockout mouse was crossed with 
mice expressing Cre recombinase under the control of several specific testis-related 
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promoters: Hsp2a (heat shock protein 2; spermatocytes), Prm (Protamine 1; post-meiotic 
spermatids), and Amh (anti-Mullerian hormone; Sertoli cells) (Appendix 1). 
 
Germ cell-specific disruption of Meig1 at the spermatocyte stage, in the presence of 
Hsp2a-Cre, resulted in a phenotype with no observable difference from that seen with 
global Meig1 disruption under the control of Cmv-Cre: male mice were infertile and 
exhibited failure of spermiogenesis. Male mice with a later germ cell-specific disruption of 
Meig1, under the control of Prm-Cre, exhibited dramatic reductions in Meig1 mRNA and 
MEIG1 protein, yet were completely fertile and displayed normal sperm count and sperm 
motility. Sertoli cell-specific disruption of Meig1 due to the action of Amh-Cre had no 
effect on sperm function, testis histology, or fertility. 
 
These data further highlight the existence of a critical point in sperm development near 
the end of meiosis as elongation and condensation are initiated, and suggest that Meig1 
plays a role at this same juncture disrupted when SPAG16S is not present. While a role 
for SPAG16S-MEIG1 interaction in manchette assembly at the round spermatid stage 
cannot be firmly established, we hypothesize this highly plausible mechanism on the 
basis of these collected data. We speculate that the Spag16 gene has evolved to 
regulate its own expression, with nuclear SPAG16S coordinating the assembly and 
trafficking of cytoskeletal components with which cytoplasmic SPAG16L will interact in 
the axoneme. This hypothesis is consistent with the observation the SPAG16S regulates 
SPAG16L expression (Chapter 2), and is consistent with the relatively moderate, 
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“downstream” phenotype observed in mice lacking SPAG16L compared to the 
spermiogenesis arrest seen with concurrent disruption of SPAG16S. 
 
RC/BTB2 
The same study that identified MEIG1 as a SPAG16 binding partner (Tang, Lalli et al. 
1982; Berruti and Paiardi 2011) also elicited RC/BTB2 as a candidate SPAG16 interactor 
following a yeast two-hybrid screen. Like Spag16, murine Rc/btb encodes both a somatic 
isoform and a testis-specific isoform. The testis-specific transcript, Rc-btb2, appears in 
male mice at day 8 after birth but reaches high levels of expression at day 20 (Wang, 
Teves et al. 2012)(http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387240/), concurrent 
with the first wave of spermatogenesis and slightly preceding expression of Spag16S at 
day 20 (Chapter 2). The RC-BTB2 protein is not heavily expressed in testis until day 30, 
at which point the first cohort of round and elongated spermatids has been produced. 
 
A full-length GFP-tagged RC/BTB2 construct and a GFP-tagged BTB domain alone were 
present asymmetrically along the nuclear membrane of transfected CHO cells. In  mouse 
testis sections, RC-BTB2 was observed in round spermatids, where it co-localized 
significantly with a marker for the acrosome, peanut lectin. The acrosome is a highly 
conserved structure in male germ cells present across one side of the nucleus at the 
beginning of spermiogenesis. This organelle is believed to derive from the Golgi and 
function as a spermiogenesis-specific secretory vesicle (Yu, Ng et al. 2008). While 
SPAG16 interaction data remain limited to the yeast two-hybrid screen, the timing of RC-
BTB2 condensation and its specific nuclear location are consistent with the observation 
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that SPAG16S-related proteins localize discretely at the beginning of spermiogenesis, 
and seem to play crucial roles in trafficking and assembly of spermiogenesis-specific 
cellular components. 
 
SOX5 
Given the strong evolutionary conservation of axoneme genes, many of them are subject 
to common regulatory mechanisms. One transcription factor gene, Foxj1, has been 
established as a master regulator of ciliogenesis (Okada, Ohta et al. 2004). Loss of this 
gene has been shown to fully disrupt motile cilia formation in a variety of tissues, 
including mammalian oviduct (Brody, Hackett et al. 1997), airway (Blatt, Yan et al. 1999), 
and embryo (Hiraoka, Ogawa et al. 1998). 
 
The evolution of novel isoforms (e.g. SPAG16S) from conserved axoneme genes in 
mammals supports the notion that new regulatory mechanisms must also exist to control 
the more complex array of genes activated in mammalian ciliogenesis. We examined 
Sox5, a transcription factor gene that expresses both a somatic isoform in mice and an 
isoform first discovered in testis, known as S-SOX5 (Zhang, Sapiro et al. 2002). 
 
Spag6, a known central apparatus gene and an important interaction partner of 
SPAG16L (Kiselak, Shen et al. 2010), contains several predicted SOX5 binding sites in 
its promoter region (Kiselak, Shen et al. 2010; O'Toole, Giddings et al. 
2012)(http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945543). The S-SOX5 transcript 
and protein are present in murine testis, lungs, and brain – all tissues with motile cilia. 
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We demonstrated that SOX5 was able to elicit Spag6 promoter function both 
independently and synergistically with FOXJ1 in model epithelial cell lines (BEAS-2B = 
respiratory; MDCK = kidney). While data from this work focuses on the Spag6 promoter, 
Spag16L and Spag17 promoters are also responsive to SOX5, suggesting that S-SOX5 
may play a general role in cilia formation in mammals. Interestingly, the putative 
Spag16S promoter region was not responsive to S-SOX5 (data not shown), which may 
indicate a temporally different activation and/or an inability to function in ciliated cell types 
other than male germ cells. Similar to the work discussed here on SPAG16, we 
hypothesize that elucidating the roles of the S-SOX5 protein may help clarify the unique 
aspects of mammalian ciliogenesis. 
 
Future Directions 
Spermatogenesis has been extensively studied in both mice and humans, and to a 
somewhat lesser extent in rats. Critical genes have been suggested by Chlamydomonas 
work on the axoneme, and the mammalian functions of these genes explored largely 
through the use of transgenic mouse models. Yet a lack of comprehensive gene 
expression studies across species limits the insights of comparative biology with respect 
to spermatogenesis. 
 
Recent work in the field has utilized advanced imaging techniques to compare human 
and Chlamydomonas cilia, and thus highlight the fact that important differences exist in 
both the structure and composition of these related structures; Chlamydomonas and 
Homo sapiens are separated evolutionarily by over a billion years, and there have been 
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design tweaks along the way (Hoops and Witman 1983). Prior studies have pointed out 
Chlamydomonas structures lacking in human cilia, such as certain bridges between outer 
doublets and projections from the outer doublets (Wanner, Salathe et al. 1996; Silflow 
and Lefebvre 2001). Additionally, it is known that Chlamydomonas flagella can express 
two waveforms in their flagella, while human cilia are capable of only one waveform 
(Silflow and Lefebvre 2001). 
 
Our work is particularly interested in the evolution of the central pair, the axoneme region 
where SPAG16L enables assembly and coordination of the core structure of the 
cytoskeleton. Interestingly, it has been observed that the central pair rotates in 
Chlamydomonas, causing a gradual twist within the flagellum, whereas the central pair is 
rotationally static in humans (O'Toole, Giddings et al. 2012). Instead, connections 
between the central pair (specifically C2) and the outer spokes are enhanced in humans 
(Lechtreck, Delmotte et al. 2008). This same phenomenon has been observed in mice 
(The International HapMap Consortium 2003), which supports the hypothesis that 
mammalian axonemes express important differences from Chlamydomonas standards as 
a result of shared evolutionary history. Speculatively, we hypothesize that the presence 
of SPAG16 in the center of the axoneme may have conferred built-in evolutionary 
flexibility, as WD protein promiscuity may allow for the introduction and interaction of new 
polypeptides. 
 
In Chapter 3 I discussed the conservation of Spag16 in eukaryotes, yet analysis of 
isoform evolution is somewhat speculative in light of current predictive, rather than 
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established, data from other mammalian species. We speculate that the evolution of 
SPAG16S and its testis-specific interaction partners may reflect a branch in 
spermatogenic strategies; however, at present it is not possible to conclusively state 
which species express this isoform and which do not, and thus we remain insufficiently 
informed to describe the molecular bases of differing spermatogenesis mechanisms. 
 
When both SPAG16 isoforms are disrupted, but not when SPAG16L alone is disrupted, 
murine spermatogenesis is arrested at the junction between meiosis and 
spermiogenesis. When the SPAG16S interaction partner MEIG1 is not present in mouse 
male germ cells at the late stages of meiosis, males are infertile, and an important 
structure responsible for intracellular trafficking during spermiogenesis fails to assemble. 
RC/BTB2, another potential interaction partner of SPAG16S, assembles at the sperm 
nuclear head during the same stage of sperm development that appears to require both 
SPAG16S and MEIG1. Just prior to condensation and elongation, as haploid round 
spermatids begin the last stage of specialized development, SPAG16S becomes highly 
concentrated in transient sub-nuclear structures known as speckles, splicing factor-
enriched structures which are only somewhat understood in somatic cells and virtually 
unexplored in male germ cells. 
 
I have presented new information on a gene that plays two highly distinct roles in male 
fertility, yet I have also demonstrated that the two isoforms of this gene are related in 
their expression and actions. Evidence from studies of Spag16 interaction partners 
suggests that the germ cell-specific SPAG16S may play a role in the nucleus to enable 
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formation of the specialized structures in developing sperm that guide cytoplasmic 
SPAG16L to its established location with the central apparatus of the “9 + 2” axoneme. 
Future studies to define expression of non-canonical SPAG16 isoforms and further 
elucidate mechanisms by which haploid male germ cells coordinate nuclear 
condensation and elongation will continue to clarify the numerous roles of the Spag16 
gene. 
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